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Abstract 
 
Objective: To document and review advances and groundbreaking progress in 
cardiac and body magnetic resonance (MR) at ultrahigh fields (UHF, B0≥7.0 T) with 
the goal to attract talent, clinical adopters, collaborations and resources to the 
biomedical and diagnostic imaging communities. 
   
Methods: This review surveys traits, advantages and challenges of cardiac and body 
MR at 7.0 T. The considerations run the gamut from technical advances to clinical 
opportunities. Key concepts, emerging technologies, practical considerations, frontier 
applications and future directions of UHF body and cardiac MR are provided. 
Examples of UHF cardiac and body imaging strategies are demonstrated. Their 
added value over the kindred counterparts at lower fields is explored along with an 
outline of research promises. 
 
Results: The achievements of cardiac and body UHF-MR are powerful motivator and 
enabler, since extra speed, signal and imaging capabilities may be invested to 
overcome the fundamental constraints which continue to hamper traditional cardiac 
and body MR applications. 
 
Conclusions: If practical obstacles, concomitant physics effects and technical 
impediments can be overcome in equal measure, sophisticated cardiac and body 
UHF-MR will help to open the door to new magnetic resonance imaging and 
spectroscopy approaches for basic research and clinical science; with the lessons 
learned at 7.0 T being transferred into broad clinical use including diagnostics and 
therapy guiding at lower fields.  
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heteronuclear MR; MR technology; radio frequency coils 
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List of Abbreviations 
 
 
λ   wavelength 
ε   permittivity 
σ   electrical conductivity 
1H   hydrogen protons 
23Na MRI   sodium magnetic resonance imaging 
31P MR   phosphorous magnetic resonance 
AMI   acute myocardial infarction 
ATP   adenosine triphosphate 
B0    main magnetic field strengths  
B1+    electromagnetic transmission field  
BMI    body mass index 
BMR   body magnetic resonance 
CEM43°C  cumulative equivalent minutes at 43 degrees celsius 
CAI   coronary artery imaging 
CMR   cardiac magnetic resonance 
CP-like   circularly polarized-like 
CPU   central processing unit 
DREAM  dual refocusing echo acquisition mode 
DWI   diffusion-weighted imaging 
D2O   deuterium oxide 
ECG   electrocardiogram 
EMF   electromagnetic fields 
EPI   echo planar imaging 
f    frequency  
FA   flip angle  
FLASH   fast low angle shot 
FOV   field of view 
FSE   fast spin-echo 
GPC   glycerophosphocholine 
GPE   glycerophosphoethanolamine 
IEC   international electrotechnical commission 
MALSE   magnetic field alert sensor 
MHD   magneto-hydrodynamic  
MIP   maximum intensity projection 
MPS    monocyte phagocytic system  
MRA   magnetic resonance angiography 
MRC   magnetic resonance cholangiography 
MRS   magnetic resonance spectroscopy 
NA   number of averages 
Na+   sodium 
NaCl    sodium chloride  
PC   phosphocholine 
PCr   phosphocreatine 
PD   proton density 
PE   phosphoethanolamine 
PINS   power independent number of slices 
Pi1 and Pi2  two phosphate peaks 
pTX   parallel transmission 
R1   longitudinal relaxivity 
R2   transversal relaxivity 
RF    radio frequency 
RFPA   radio frequency power amplifiers  
RX   radio frequency reception 
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SAR    specific absorption rate 
ShMOLLI  shortened modified look locker inversion 
SD   standard deviation 
SNR   signal-to-noise ratio 
SSFP   steady state free precession 
TX   radio frequency transmission 
T1   longitudinal relaxation time 
TE01 mode  transverse electric mode 01 
T2   transversal relaxation time 
T2*   effective transversal relaxation time 
TE    echo time 
TIAMO   time-interleaved acquisition of modes 
TR   repetition time  
UHF-MR   ultrahigh field magnetic resonance 
VOPS   virtual observation points 
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Short abstract 
This work documents and reviews advances and progress in cardiac and body 
magnetic resonance technology at ultrahigh fields and its application in forefront 
research and in early clinical applications. The achievements of ultrahigh field 
cardiac and body magnetic resonance are shown to be a powerful motivator and 
enabler, since the extra speed, signal and imaging capabilities may be invested to 
overcome the fundamental constraints which continue to hamper traditional cardiac 
and body magnetic resonance applications at lower magnetic field strengths. 
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Introduction 
The growing number of reports referring to technology transfer and 
explorations into body and cardiovascular applications is an inherent testament to 
the advancements of magnetic resonance (MR) at ultrahigh magnetic field strengths 
(B0≥7.0 T, f ≥298 MHz). Pioneering explorations into ultrahigh field (UHF) body MR (BMR) 
document the progress in liver, renal, abdominal, pelvic and prostate imaging and 
spectroscopy (1-24). Early applications of UHF cardiac MR (CMR) manifest the 
advances for imaging and spectroscopy of the heart and the large vessels (25-59). 
These technical and pilot studies respond to unsolved problems and unmet needs of 
today’s clinical body/cardiac MR. These developments are fueled by the signal-to-
noise ratio (SNR) advantage inherent to higher magnetic field strengths and are 
driven by explorations into novel MR technology.  
The progress is heartening and creates the legitimate temptation to sing the 
praise of UHF-BMR/CMR. Transferring UHF-BMR and UHF-CMR into the clinic remains a 
major challenge though (32) since the advantages are sometimes hampered by a 
number of concomitant physics related phenomena and by practical impediments. 
It is no secret that these obstacles bear the potential to spoil the benefits of UHF-
CMR/BMR. Although reports from clinical early adopters of 7.0 T BMR/CMR remain 
largely anecdotal at this point, momentum is gathering for broader applications 
oriented feasibility studies and for clinical studies, which will be enabled by 
increasingly robust and streamlined hardware and software platforms.  
Recognizing the technical advances and clinical opportunities of UHF-
BMR/CMR together with the need for broader clinical studies this review is an attempt 
to make the (bio)medical and diagnostic imaging communities aware of this 
productive ferment, so as to engage the interest of potential clinical adopters, to 
inspire collaborations across disciplinary boundaries and to attract basic scientists, 
engineers, hardware professionals, translational researchers, applied scientists  and 
new entrants into the field; with the goal to advance the capabilities of UHF-
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BMR/CMR by fostering explorations into the many remaining unresolved problems 
and technical obstacles. In the sections that follow, examples of enabling UHF-
BMR/CMR technology and their applications are provided. Encouraging 
developments into multiple channel radiofrequency (RF) concepts are reviewed. 
Advances in imaging methodology and progress in RF pulse design are discussed. 
Early and frontier applications of BMR/CMR at 7T are surveyed together with the 
clinical opportunities for high spatial resolution MR, parametric mapping, MR 
angiography and real time imaging; all being facilitated by the traits of UHF-MR. Liver, 
renal and prostate UHF-BMR applications are presented. Heteronuclear UHF-
BMR/CMR applications are explored including sodium MR and phosphorous MR. 
Practical considerations of UHF-BMR/CMR are outlined. The subjective acceptance 
during UHF-BMR/CMR examinations is discussed. Insights into RF heating induced by 
conductive stents and implants along with RF power deposition considerations are 
provided. Current trends in UHF-BMR/CMR are considered together with their clinical 
implications. A concluding section ventures a glance beyond the horizon and 
explores future directions. Of course, ultrahigh field BMR/CMR is an area of vigorous 
ongoing research, and many potentially valuable developments will receive only 
brief mention here.  
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Technical Solutions for Ultrahigh Field Body and Cardiac MR  
Enabling Radio Frequency Coil Technology 
At ultrahigh fields the crux of the matter is that the wavelength becomes 
sufficiently short versus the size of the upper torso, abdomen and pelvis. As deep-lying 
organs surrounded by the lung, stomach, bowels and other inhomogeneous tissue 
structures within the comparatively large volume of the thorax, abdomen and pelvis, 
the anatomy targeted in CMR and BMR is particularly susceptible to non-uniformities 
in the RF transmission field (B1+). These detrimental B1+ phenomena can cause 
shading, massive signal drop-off or even signal void and hence bear the potential to 
offset the benefits of UHF-BMR/CMR due to non-diagnostic image quality.  
To address this obstruction for broader clinical studies a plethora of reports 
eloquently refers to the development of enabling RF technology tailored for BMR and 
CMR at 7.0 T. In fact, the momentary non-uniformities in the transmission fields in the 
thorax and abdomen are generally so significant that the use of traditional birdcage 
body coils at 298 MHz become elusive if not prohibitive. This need has inspired 
explorations into novel RF technology including cardiac and body optimized multi-
channel coil array configurations. Research directions include (i) local transceiver 
(TX/RX) arrays and (ii) multi-channel transmission arrays in conjunction with multi-
channel local receive arrays.  
 Arguably, the wide spectrum of BMR/CMR applications is ranging from large 
volume imaging to localized spectroscopic probing which renders the design of a 
single optimal many-element RF coil configuration elusive. Obviously, the selected RF 
coil design should first of all meet the requirements of patient safety, patient comfort 
and ease of clinical use to harmonize the technical specifications with the clinical 
needs. This includes light weight, flexibility, capability to accommodate multiple body 
habitus and anatomical variants, a modular and multi-dimensional arrangement of 
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coil elements or building blocks together with a sensitive region large enough to 
cover the target anatomy in the upper torso, abdomen and pelvis (32).   
 Multi-channel RF coil designs tailored for UHF-BMR/CMR involve rigid, flexible 
and modular configurations. The gestation process revealed a trend towards a larger 
number of transmit and receive elements  (31,35,37-39,53) to improve anatomic 
coverage and to advance the capabilities for transmission field shaping (60). 
Pioneering developments made good use of building blocks that include stripline 
elements (6,25,26,61,62), elecrical dipoles  (46,62-65), dielectric resonant antennas 
(55) and loop elements (31,35,37-39,53), with the number of independent elements 
ranging from two to thirty two.  
 Loop element based CMR/BMR optimized 7.0 T transceiver configurations 
were reported for an 4-channel TX/RX design that is equipped with two anterior  and  
two  posterior  elements (Figure 1a) (35). An alternative loop array comprises eight 
TX/RX channels split into five anterior and three posterior elements (Figure 1b) (37). 
Both configurations make use of a one-dimensional arrangement of the elements. 
This setup constrains the degree of freedom for transmission field optimization and for 
parallel imaging. A two-dimensional arrangement of loop elements uses sixteen TX/RX 
channels with the elements being distributed to eight anterior and eight posterior 
elements; both arranged in a 2 x 4 array  (Figure 1c) (39). This approach was 
extended to a more sophisticated modular 32 channel TX/RX array shown in Figure 1d 
(53). This configuration comprises four planar (posterior section) and four modestly 
shaped (anterior section) modules (53); each module being fitted with four 
independent transceiver loop elements (2 x 2 array). 
 Various stripline element based 7.0 T transceiver configurations were proposed 
for cardiac and body UHF-MR. In a pioneering 8 element transverse electromagnetic 
field (TEM) transceiver array design each element was independently connected to 
a dedicated RF power amplifier (25). Other stripline array configurations run flexible 
designs consisting of a pair of four (Figure 2a) or eight stripline elements, one placed 
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anterior and the other posterior to the torso (26,61). Another practical solution 
comprising an eight channel stripline transceive array (Figure 2b) that uses 
sophisticated automated tuning with piezoelectric actuators was accomplished (54). 
  Electric dipoles have been shown to be suitable for CMR and BMR at 7.0 T 
including deep seated targets such as the prostate and the pelvis (46,63). Electric 
dipoles run the trait of a linearly polarized current pattern, where RF energy is directed 
perpendicular to the dipole along the Poynting vector to the subject resulting in a 
symmetrical, rather uniform excitation field with increased depth penetration (63). 
Early implementations include straight dipole elements (63). To enable efficient power 
transmission from dipole antennae the length of the antenna needs to be adjusted to 
the transmission frequency so that the antenna size can be as long as 35-50 cm for a 
straight, self-resonant half wavelength dipole antenna at 297MHz. This geometry is 
suitable for large volume body MRI at 7.0 T but imposes a constraint (i) for the design 
of many element, two-dimensional transceiver arrays confined to cardiac fields of 
view and (ii) for parallel imaging along all standard and multi-oblique cardiac views. 
The need for densely packed multichannel transceiver coil arrays tailored for UHF-
BMR/CMR inspired explorations into electric dipole configurations that comprise 8 or 
16 bow tie antenna building blocks as shown in Figure 1e,f. Each of the building 
blocks contains a bow tie shaped λ/2-dipole antenna immersed in D2O (46) which is 
an MR inactive molecule with a permittivity of ε≈81 at 298 MHz. This approach helps to 
shorten the effective antenna length. To establish a CMR/BMR array of 16 
independent TX/RX channels eight bow tie antenna building blocks were combined 
to form an anterior and a posterior coil section, each in a 4 x 2 array (Figure 1f).  
Improvements in the compactness of dipole antenna arrays were also 
accomplished by incorporating lumped element inductors, by using fractionated 
dipoles (Figure 2c) or by employing meander structures (66-68). The requirements of 
UHF-BMR/CMR along with ultimate intrinsic SNR and current pattern considerations 
inspired alternative dipole antenna designs. One important development is bent 
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electric dipoles (69). Other configurations include circular dipoles, which consist of a 
circular conductor with a feed point on one side and a gap on the other (70). 
Recently proposed dipole antenna variants include folded dipoles (71). 
 Another conceptually very much appealing building block design is the 
dielectric resonant antenna fabricated with high permittivity, low loss  ceramics (55). 
These building blocks are designed to operate in the TE01 mode at 298 MHz (55). This 
resonance mode dictates the disc geometry which for example resulted in a 
diameter of 86 mm and a height of 39 mm for BaSrTiO3 resonators with a relative 
permittivity of 165 (55). Inductive coupling using a small non-resonant coupling loop 
per resonator was applied for impedance matching and for coupling energy into the 
ceramic resonator. To form an 8 element transceiver array four building blocks were 
placed on top of the anterior chest while 4 building blocks were positioned posterior 
to the upper torso (Figure 2d). 
 To summarize, stripline elements, dielectric resonant antennae, loop elements 
and electric dipoles are valuable building blocks for local transceiver coil 
configurations customized for BMR and CMR at 7.0 T. To this end ultimate intrinsic 
signal-to-noise ratio (UISNR) considerations outlined that loop- and dipole current 
patterns contribute equally to UISNR at 7.0 T (72,73). For field strengths of B0≥9.4 T 
current patterns are dominated by linear (dipole type) current patterns (72,73), which 
provides motivation for shifting the weight to dipoles versus loop and stripline 
elements. 
 
Multi-Channel RF Chain 
 To translate the capabilities of multi-channel RF coil configurations into 
practical value advances in MR systems hardware abounded. Contemporary UHF-MR 
systems  architecture supports multi-channel transmit arrays to be driven in two 
modes, using (i) an array of independent feeding RF power amplifiers (RFPA) with 
exquisite control of phase, amplitude or even complete RF waveforms for all 
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individual channels or (ii) a single feeding RFPA. For the single feeding RFPA regime 
the amplifier output is commonly split into fixed-intensity signals using RF power 
splitters. Phase adjustments for individual coil elements or groups of coil elements are 
accomplished with phase-shifting networks or coaxial cables. This setup provides a 
practical solution which can be made readily available for a large number of MR 
sites. In today’s research implementations RFPA’s with up to 16 kW peak power are 
used for the single feeding RFPA mode. State of the art multi feeding RFPA 
implementations support up to 16 RF amplifiers each providing up to 2 kW adjustable 
RF output power. This setup provides software driven control over phase and 
amplitude by modulating the applied input signal. Moreover it enables sophisticated 
parallel transmission of independent RF waveforms to every channel. On the journey 
to a broader range of UHF-BMR/CMR applications it is beneficial if RF coil 
configurations provide flexibility which supports single feeding as well as multiple 
feeding RFPA regimes without major changes in cabling and other components (53). 
 
Advances in Imaging Methodology  
Advances in imaging methodology comprise two main categories for UHF-
BMR/CMR: (i) novel approaches for transmission field mapping and (ii) new 
technologies for transmission field shaping. 
The knowledge of the spatial B1+ distribution generated by coil arrays is pivotal 
for UHF-BMR/CMR to manage transmission fields across the target region including 
signal excitation, signal refocusing, and magnetization preparation.  B1+ mapping 
approaches commonly used are mainly magnitude-based and are generally 
confined to the ratios or the fit of signal intensity images (74-81). For this purpose sets 
of images are acquired using either two flip angles (75-77), identical flip angles but 
different repetition times (TR) (79), variable flip angles (78,80) or signals from spin-
echoes and stimulated-echoes (74), as well as signals from gradient-echoes and 
stimulated-echoes (82). It should be noted that B1+ mapping is not a need limited to 
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transceiver arrays tailored for 1H UHF-MR. For instance B1+ mapping has been applied 
to 23Na MRI to support quantification of sodium tissue content (83).  
Many of the B1+ mapping techniques rely on the knowledge of the steady 
state magnetization B1+ (75). This makes large volume coverage flip angle mapping 
time consuming due to the speed constraints dictated by the need for rather long 
repetition times (TR > 5 T1) to avoid T1 saturation effects. Also, the competing 
constraints of cardiac and respiratory motion limit the viable window of data 
acquisition so that B1+ mapping of the heart and body is commonly limited to single 
slice breath-held acquisitions. To address the anatomic coverage and speed 
constraints a B1+ mapping approach was proposed which is based on a 
magnetization prepared transient gradient-echo sequence and that facilitates sub-
second acquisitions (82). The speed gain renders the dual refocusing echo acquisition 
mode (DREAM) suitable for large volume coverage multi-slice acquisitions within 
clinically acceptable breath-hold durations. B1+ mapping with DREAM was shown to 
be adjuvant for liver imaging which benefits from the improvements in  flip angle 
accuracy and transmission field uniformity over the target volume (84). The propensity 
of DREAM to blood flow is a remaining concern for cardiovascular and body B1+ 
mapping. To offset the flow sensitivity of DREAM a Motion-Sensitized Driven-Equilibrium 
magnetization preparation was used which showed ample suppression of blood 
signal in the cardiac chambers and in large vessels (85). 
Phase-based techniques present an alternative for B1+ mapping, and were 
reported to be more accurate versus magnitude-based methods for the low flip 
angle regime (86). These methods commonly make use of a composite or off-
resonance RF-pulse to encode the spatial B1+ information into the phase of the 
magnetization vector. Most phase based methods, however, make use of non-
selective pulses for volume excitation in conjunction with 3D imaging schemes (87-
89). This approach results in relatively long acquisition times that often exceed 
clinically acceptable breath-hold periods along with a pronounced susceptibility for 
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respiratory motion artifacts. Realizing these limitations, the feasibility of cardiac gated, 
single breath-hold B1+ mapping has been demonstrated (90) using a 2D phase-based 
Bloch-Siegert approach (91). The reduction of the duration of the Fermi pulse allowed 
for short TR which enabled scan times accommodated by a single breath hold. It is a 
remaining  issue, that phase based B1+ mapping might not be exclusively governed 
by the phase accrual induced by the composite RF pulse but might also reflect 
phase contributions due to blood flow and cardiac motion. Preliminary results did not 
show major changes in the calculated flip angle at the blood/myocardium interface 
and hence indicate that blood flow related phase contributions might be minor (90).  
Notwithstanding the advances in B1+ mapping methodology transmission field 
mapping of individual coil elements at 7.0 T has been primarily established for head 
imaging (92-94) but remains a challenge for UHF-BMR/CMR due to depth penetration 
constraints and susceptibility artifacts. To cope with this challenge B1+ profiles are 
often derived from numerical electromagnetic field (EMF) simulations (39,53,95). For 
this purpose the  transmit  phases  for each coil element are adjusted  using  iterative  
algorithms  to improve transmission field  homogeneity  in  a  region of interest  
encompassing the  heart or the abdomen using a human voxel  model  (96). To 
ensure that the relative B1+ distributions of the individual coil elements derived from 
the EMF simulations accord with reality it is essential that EMF simulations are validated 
against MR measurements using phantoms filled with a dielectric liquid that resemble 
the dielectric properties of the target organ/tissue as outlined in (Figure 3). While the 
single feeding RFPA mode provides a practical solution it comes with the caveat that 
subject specific B1+ shimming is not supported. Hence the applicable range of body 
geometries and body mass indices (BMI) is centered around the reference subject or 
the human voxel model used for B1+ optimization. Notwithstanding this drawback 
clinically acceptable image quality can be obtained for UHF-CMR for a common 
range of BMI’s without the need of patient-specific adjustments (38,39,53), bringing 
this technology closer to product development and broader clinical use.  
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Based upon  a priori acquired B1+ maps derived for all individual transmit 
channels of an coil array B1+ shimming can be used to reduce RF non-uniformities 
across the torso using the degrees of freedom of multi-channel transmission to shape 
the transmission field for UHF-CMR/BMR. Figure 4 shows an example for B1+ uniformity 
improvements across a 4 chamber view of the heart using a 32 channel TX/RX coil in 
conjunction with B1+ shimming that makes use of (i) a B1+ optimized phase setting 
using 32 elements, (ii) a phase setting per building block each comprising 4 elements 
and (iii) a circularly polarized-like (CP-like) phase setting for all elements (53). 
The acquisition of two or more time-interleaved images recorded with 
complementary RF excitation modes is an extension of static RF shimming in the single 
feeding RFPA regime (97). This methodology helps to mitigate signal voids due to B1+ 
non-uniformities by combining the B1+ spatial RF excitation patterns (98). The 
enhanced B1+ uniformity comes with a scan time or signal-to-noise ratio drawback. 
This spatio-temporal resolution penalty can be offset by combined reconstruction of 
virtual coil elements in conjunction with parallel imaging techniques (97). 
Arguably, the single RFPA B1+ shimming regime is static and offers limited 
capabilities if more sophisticated and dynamic B1+ adjustments are needed to 
support cascades of B1+ shimming stages including slice-by-slice specific B1+ shimming, 
subject specific B1+ trimming or magnetization preparation modules driven by B1+  
efficiency requirements versus imaging modules governed by B1+uniformity needs. 
Dynamic shimming is the forte of the multi feeding RFPA’s mode in conjunction with 
sophisticated pulse sequence developments which support cascades of dynamic B1+ 
shimming stages that balance the needs of preparation modules common in body 
and cardiac imaging such as inversion, fat suppression or blood suppression, pencil 
beam excitation across the diaphragm for navigator gated respiratory motion 
compensation and rapid imaging modules. Frontier BMR/CMR implementations of 
dynamic B1+ shimming at 7.0 T include 2D CINE imaging (99), coronary MR 
angiography (100), renal MR angiography (12), 4D flow MR angiography of the entire 
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aorta (101) and arterial spin labeling perfusion imaging of the kidneys (102) which 
demonstrated improved excitation efficiency, increased SNR of myocardium and 
blood, enhanced blood/myocardium contrast or helped to balance the B1+ 
uniformity with B1+ efficiency (103). 
 
Progress in RF Pulse Design 
Multi-channel transmission (104-107) using spoke RF pulses presents a major 
breakthrough for pulse sequence developments tailored for UHF-BMR/CMR (49). A 
juxtaposition of the two-spoke approach with B1+ shimming revealed an enhanced 
excitation fidelity or a reduced RF pulse energy for the two-spoke technique (49). This 
benefit holds the promise to be instrumental for a broader range of CMR 
applications, including uniform excitation for parametric mapping used for tissue 
characterization. Current pulse designs for two-spoke parallel transmission RF pulses 
make use of a single set of B1+ /B0 maps though. This approach may not be suitable 
for subsequent scans acquired at another respiratory phase because of organ 
displacement, which might induce severe excitation profile degradation. To address 
this issue, a tailored parallel transmission RF pulse design which is immune for 
respiration induced B1 + /B0 variations has been recently proposed (58). In analogy to 
the CMR implementation the two-spoke approach can be exploited to mitigate B1+ 
inhomogeneity in target regions encompassing the pelvis, the abdomen or the liver 
(15). Multi-band spokes pulses afford simultaneous multi-slice acquisitions with 
enhanced flip angle homogeneity but minimal increase in integrated and peak 
radiofrequency power (108). 
On the RF pulse design side adiabatic RF pulses and composite RF pulses offer 
a practical solution to offset the B1+ uniformity constraints. These RF pulses provide 
nearly constant flip angles over a wide B1+ range, with a common lower limit of 
approximately 60% of the expected B1+. This advantage comes at the cost of RF 
power deposition. This issue is pronounced for fast spin-echo based imaging 
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techniques which exhibit an increased propensity to B1+ inhomogeneities. The power 
deposition constraint manifests itself in limited spatial coverage by allowing only few 
slices for fast spin-echo imaging. To relax this caveat adiabatic RF pulses are 
commonly prolonged with pulse durations exceeding 10 ms to reduce peak RF power 
(17). Obviously, the long inter-echo times put an extra burden onto the point spread 
function of fast spin-echo imaging which can inadvertently diminish the usefulness of 
the spatial resolution enhancements of UHF-BMR/CMR. Slice accelerated acquisition 
schemes using power independent number of slices (PINS) RF pulses which perform 
spatially periodic excitation and refocussing provide means for relaxing RF power 
deposition in spin-echo based imaging at 7.0 T (109).  
Adiabatic RF pulses were also used in spectrally selective adiabatic RF 
inversion based fat suppression with the goal to enhance contrast between coronary 
lumen blood pool and epicardial fat (30). Hyperbolic-secant RF pulses were 
employed to form a saturation pulse train optimized for first pass myocardial perfusion 
MRI at 7.0 T (51).  
To deal with respiratory motion in BMR/CMR prospective navigator gating and 
tracking using 2D selective pencil beam excitation is another area of activity for RF 
pulse developments (29). For CMR at 7.0 T the heart/lung interface rather than the 
diaphragm is used for navigator localization (29). For this purpose the duration of the 
2D selective pencil beam navigator RF pulse was significantly decreased versus 
protocols established at 3.0 T to master susceptibility artifacts at the heart/lung 
interface (29).  
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Applications and Clinical Opportunities 
   
Cardiac Chamber Quantification  
Early UHF-CMR applications demonstrated the usefulness of 2D CINE spoiled 
gradient-echo imaging (FLASH) for cardiac chamber quantification of the left 
(28,34,36) and right ventricle (44) at 7.0 T. 2D CINE FLASH provides high quality images 
with uniform signal intensity distribution and high blood/myocardium contrast over the 
entire heart  as demonstrated in Figure 5. Cardiac chamber quantification at 7.0 T 
agrees closely with LV and RV parameters derived at 1.5 T (34). 
 The baseline SNR gain at 7.0 T can be translated into spatial resolution 
enhancements versus the kindred counterparts at lower field strengths. Figure 6 
surveys four chamber and short axis views of the heart obtained with a standardized 
CMR protocol (110,111) and with an enhanced spatial resolution. The latter protocol 
reduces the voxel size from 19.4 mm3 to 1.6 mm3, equivalent to a twelve-fold 
improvement in the spatial resolution versus a standardized clinical CMR protocol. This 
fidelity approaches an effective anatomical spatial resolution – voxel size per 
anatomy – which resembles that demonstrated for animal models (112). The overall 
image quality and improvements in spatial resolution enabled the visualization of fine 
subtle anatomic structures including the compact layer of the free right ventricular 
wall and the remaining trabecular layer. Pericardium, mitral and tricuspid valves and 
their associated papillary muscles, and trabeculae are identifiable. For the short axis 
views a standard deviation of the signal intensity over the myocardium of 
approximately 20 % was observed.  
 A recent implementation demonstrated the applicability of slice selective 
two-spoke parallel transmit RF pulses in cardiac 2D CINE imaging at 7T (49). For this 
purpose cardiac gated, breath-held B1+ multi-channel calibration maps and ∆B0 
maps were acquired to guide the amplitude and phase modulated RF pulse design 
for each channel. With the two-spokes approach the B1+ field was found to be 
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improved significantly for the posterior region of a four chamber view of the heart 
including the atria and the large vessels (49). With a two spoke pulse setting 
transmitter voltage/RF pulse energy could be increased by 22%/50% to obtain higher 
blood/myocardium contrast without exceeding the RF power deposition limits (49). 
    
First Pass Myocardial Perfusion Imaging 
Clinical CMR assessment of ischemic heart disease includes rapid first-pass 
contrast agent enhanced myocardial perfusion MRI (111). Numerous saturation-
recovery-based perfusion techniques have been proposed to capture first-pass 
kinetics with one- or two-heart-beat temporal resolution. Saturation methods 
established at lower fields are suboptimal for myocardial perfusion imaging at 7.0 T 
(51). To address this issue a novel saturation pulse train consisting of four hyperbolic-
secant (HS8) radiofrequency pulses was proposed for effective saturation of 
myocardium at 7.0 T (51). This approach facilitated an average saturation efficiency 
of 97.8% in native myocardium and afforded the first series of human first-pass 
myocardial perfusion images at 7.0 T (51). The ability to produce exquisite in-plane 
spatial resolution at 7.0 T may offer greater diagnostic value for myocardial perfusion 
assessment and supports an extension of the perfusion assessment to the right 
ventricle. With sufficient acceleration and imaging speed, perfusion imaging is on the 
verge for 3D whole heart coverage acquisitions (113) which might be furthered by 
the traits of UHF-MR.  
  
Myocardial T2* Mapping 
The ability to probe for changes in tissue oxygenation using T2* sensitized 
imaging/mapping offers the potential to address some of the spatial and temporal 
resolution constraints of conventional first pass perfusion imaging and holds the 
promise to obviate the need for exogenous contrast agents. For T2* mapping at 7.0 T 
a reasonable  B0 uniformity across the heart is key so that susceptibility weighting is not 
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dominated by macroscopic B0 field inhomogeneities but rather by microscopic B0 
susceptibility gradients (42). A mean peak-to-peak B0 difference of approximately 65 
Hz was found across the left ventricle (42), which compares well with 3.0 T (114) and 
1.5 T studies (115). For myocardial anterior, anterolateral and inferoseptal segments a 
mean in-plane B0 gradient of approximately 3 Hz/mm was observed. With this B0 
uniformity high spatial resolution myocardial T2* mapping at 7.0 T is feasible (42,48) as 
demonstrated in Figure 7. The longest mean T2* values were found for the anterior 
(T2*=17.3 ms), anteroseptal (T2*=16.8 ms) and inferoseptal (T2*=16.3 ms) segments. 
Septal segments showed the lowest spatial variation in T2*, which is similar to that 
reported for 1.5 T and 3.0 T (48). The inferior (T2*=12.0 ms) and inferior lateral (T2*=11.4 
ms) wall yielded lowest T2* values with the spatial variation being significantly 
pronounced versus 1.5 T and 3.0 T (48). The 7.0 T setup used facilitated a spatial 
resolution as good as (1.1x1.1x2.5) mm3, which helped to reduce intravoxel 
dephasing along the slice direction (42).  
Detailing magnetic field strength dependence revealed that myocardial T2* 
decreases linearly with B0 with the mean global T2* of healthy myocardium being 
approximately 14 ms at 7.0 T versus 27 ms at 3.0 T (116) and approximately 37 ms at 
1.5 T (117). This makes the susceptibility effect due to (patho)physiology of interest 
more pronounced, so that T2* mapping at 7.0 T might be beneficial to address some 
of the BOLD sensitivity constraints reported for the assessment of regional myocardial 
oxygenation changes in the presence of coronary artery stenosis (118). The recent 
progress in in vivo histology and in fiber orientation tracking using T2* weighted and 
susceptibility weighted MR (119-121) suggests that the linear relationship between T2* 
and B0 might provide means to gain a better insight into the myocardial 
microstructure. Since the susceptibility effects depend on the tilt angle between 
blood filled capillaries and the external magnetic field strength (115,122-124) T2* 
mapping at 7.0 T might contribute to explorations into visualization of myocardial 
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fibers, into the examination of helical angulation of myocardial fibers or into the 
assessment of fibrotic tissue and other kinds of microstructural tissue changes.  
To avoid T2* quantification errors due to signal modulations induced by fat-
water phase shift, echo times where fat and water are in-phase are commonly used 
for T2* mapping (125). This translates into inter-echo times of ∆TE=2.2 ms at 3.0 T and 
∆TE=4.4 ms at 1.5 T. Consequently it is elusive to study temporal changes in T2* across 
the cardiac cycle at 1.5T and 3.0T due to scan time constraints which are prohibitive 
for CINE T2* mapping covering the cardiac cycle. At 7.0 T ∆TE governed by the fat-
water shift is 1.02 ms, which facilitates CINE T2* mapping customized for T2* monitoring 
across the cardiac cycle  (Figure 7) (42). The improved temporal resolution of T2* 
mapping at 7.0 T provides means for monitoring externally controlled variations of 
blood oxygenation including short periods of hypoxia and hyperoxia test stimuli 
(126,127).  
 
Myocardial T1 Mapping  
Myocardial tissue characterization using T1-weighted late gadolinium 
enhancement imaging is of proven clinical value for the assessment of ischemic heart 
diseases but also for non-ischemic myocardial diseases (111). T1-weighted imaging is 
qualitative and subjective though, which demands advancements towards 
myocardial T1 mapping (128-130). At 7.0 T increased RF transmit power and improved 
B0 shimming play complementary roles for myocardial T1 mapping which requires 
careful transmission field shaping and B0 shimming. This requirement can be managed 
if quantification of and correction for imperfect inversion is applied (47). For this 
purpose an adiabatic inversion pulse tailored for use in the heart in conjunction with a 
ShMOLLI variant was employed (47). Subject averaged inversion efficiencies ranging 
from -0.79 to -0.83 (perfect inversion would provide -1) were accomplished across 
myocardial segments (47). T1 of normal myocardium has been reported to be 
(1925±48) ms at 7.0 T  (47) versus (1166±60) ms at 3.0 T (131) and (721±37) ms at 1.5 T 
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(130). The prolonged T1 relaxation times at 7.0 T provide an enhanced 
blood/myocardium contrast superior to 1.5 T which afforded a revival of spoiled 
gradient-echo imaging techniques at 7.0 T. Slice selective variable flip angle 
techniques provide an alternative for rapid parametric T1 mapping (132). This 
approach obviates the need for inversion recovery preparation while being fast 
enough to meet the speed requirements of cardiac MR.  
 
Fat Water Imaging 
Fat-water separated cardiac imaging provides a sensitive means of detecting 
intramyocardial fat, characterizing fibro-fatty infiltration, characterizing fatty tumors, 
and delineating epicardial and/or pericardial fat. Multi-echo Dixon approaches 
utilizing iterative decomposition have been shown to provide robust fat-water 
separation even in the presence of large field inhomogeneities (133). Equipped with 
this technology fat-water separated imaging at 7.0 T has been demonstrated for 
cardiac and body applications (134-136).  
 
Coronary Artery Imaging 
CAI remains technically challenging due to small vessel size, vessel tortuosity, 
and physiological motion (137,138). UHF-CAI studies using non-contrast gradient-echo 
imaging techniques suggested that image quality did already approach that 
achieved for CAI at 3.0 T (29,30,50). Coronary vessel sharpness at 7.0 T was found to 
be improved versus 3.0 T (30).  The early studies focused primarily on the right 
coronary. To afford appropriate coverage of all main coronary arteries  the 
capabilities of dynamic B1+ shimming  were exploited (100). The capabilities of UHF-
CAI were furthered by employing high spatial resolution CAI  (Figure 8a) (50). For this 
approach coronary vessel edge sharpness was found to be superior to the boarder 
sharpness accomplished in state-of-the-art CAI at 3.0 T. Visible vessel length and 
vessel diameter obtained at 7.0 T were competitive with 3.0 T (50).  
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Traditional frequency selective fat saturation techniques used in CAI might 
suffer from large static field variations at 7.0 T which may cause non-uniform and 
imperfect fat-suppression over the target region; an effect which bears the risk to 
obscure the delineation of coronary arteries. Here fat-water separated imaging holds 
the promise to substitute conventional preparatory fat saturation techniques (Figure 
8b). This approach also promises to offset some of the RF power deposition constraints 
which come with conventional saturation recovery based fat saturation that makes 
use of large flip angles.  
 
Vascular Imaging 
MR angiography (MRA) of the large vessels is a common cardiovascular MR 
application. MRA stands to benefit from UHF-MR. The SNR gain can be used to 
counter the noise amplification caused by acceleration techniques employed to 
meet the high spatiotemporal resolution requirements of MRA. Potential applications 
include large volume coverage, time-resolved phase velocity MRA (4D flow) which is 
an emerging technique for studying the flow pattern or wall shear stress in large 
vessels. The feasibility of aortic 4D flow at 7T was recently demonstrated (56). For this 
purpose a prospectively gated 4D flow sequence was applied. This approach 
provided a SNR enhancement of 2.2/3.7 versus 3.0 T/1.5 T for non-contrast enhanced 
acquisitions in the descending aorta (56). Another 4D flow MRA implementation at 7.0 
T made good use of dynamically applied B1+ shimming toggling a setting tailored for 
the navigator used for respiratory gating and the imaging module (101).  
Perhaps UHF-MR forms another important enabling factor to transform the 
baseline SNR advantage into improved spatiotemporal resolution of contrast 
enhanced MRA. To this end an SNR gain for contrast enhanced versus non-contrast 
enhanced 4D flow MRA was reported to be approximately 1.4 at 7.0 T which was 
found to be in accordance to 3.0 T and 1.5 T observations (56). Research continues to 
examine the impact of prolonged T1 relaxation times and altered R1 and R2 relaxivity 
p a g e  | 25 
 
of clinically approved gadolinium(III) chelate based contrast media on the 
blood/background tissue contrast at 7.0 T. These studies include the assessment of 
contrast agent doses required to accomplish maximal available contrast 
enhancement (139,140). 
 
Black Blood Imaging 
Transfer of fast spin-echo based black blood imaging to 7.0 T is of high 
relevance for advancing the capabilities of UHF-CMR for explorations into cardiac 
morphology and myocardial tissue characterization. FSE imaging at 7.0 T presents a 
special challenge due to the train of high peak RF power refocusing pulses (α ≤ 180°). 
Notwithstanding its utility for improving B1+ uniformity in UHF-FSE imaging, recent 
studies on using adiabatic pulses for UHF-FSE reported long inter echo times of up to 
15 ms; an approach which does not meet the CMR requirements.  
The feasibility of cardiac FSE imaging at 7.0 T using an eight channel 
transceiver array of bowtie antennas (Figure 1e) is demonstrated in Figure 8c. For this 
purpose a spatial resolution of (0.9 x 0.9 x 4.0) mm3 was applied, which represents an 
order of magnitude improvement versus standardized protocols of today’s clinical 
CMR practice (111). The blood suppression inherent to FSE works well in most regions 
of the heart. Only slow flowing blood in areas close to the endocardium remains 
visible. The refinement of black blood preparation modules – including double 
inversion recovery preparation – tailored for 7.0 T is anticipated to further FSE image 
quality at 7.0 T. Here a modest diffusion weighting could provide a valuable 
alternative for spoiling remaining signal induced by slow flowing blood. Figure 8c also 
indicates that the dynamic range of FSE image contrast at 7.0 T is dominated by 
subcutaneous fat signal despite the applied spectral preparation pulse, which 
requires further efforts into fat suppression techniques. Alternatively, reduced field of 
view acquisition can be exploited to exclude subcutaneous fat of the chest wall from 
the field of view. The application of double echo FSE techniques, which afford a 
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simultaneous combination of different image contrasts provides opportunities to 
advance the capabilities of UHF black blood imaging (141). Generating dual contrast 
simultaneously within one acquisition offers substantial scan time reduction. This is of 
benefit in a clinical scenario where multiple parameters/contrasts are assessed. 
Moreover, simultaneous acquisition of multiple contrasts obviates the need for slice 
co-registration when combining multiple series of images with anatomical (T2 or PD) 
and functional (DWI) contrast, which would be beneficial for CMR dealing with 
physiological motion. The use of self-calibrated parallel imaging techniques tailored 
for FSE imaging presents another opportunity to extend the capabilities of black 
blood imaging at 7.0 T (142). For this purpose the full echo of coherent FSE needs to 
be decomposed into two parities, which can be independently phase encoded (i) 
using regular sampling to derive coil sensitivity profiles and (ii) k-space undersampling 
for accelerated FSE acquisitions (142). One practical implication is that the speed 
gain of self-calibrated FSE would help to reduce examination times while improving 
both operator convenience and patient comfort. 
 
 
Real Time Imaging  
Breath-held 2D CINE acquisitions segmented over regular 10-16 heartbeats 
are the clinical standard for LV structure and function assessment. Yet, the traditional 
approach is limited by physiological (e.g. cardiac arrhythmias) constraints, which 
might cause inappropriate diagnostic information. Free breathing real time cardiac 
MRI achieves diagnostic quality in a single heartbeat (143) and bears the potential to 
change the landscape of cardiac diagnostics (144-146). These developments will 
afford an improved clinical accuracy and efficacy of CMR. The accelerated imaging 
capabilities and the anatomic coverage of multi-channel bow tie antenna arrays 
(Figure 1e,f) supported free breathing real time imaging of the heart and of the aorta 
at 7.0 T (Figure 9). The spatial resolution of (1.2 x 1.2 x 6.0) mm3 and the frame rate of 
30 frames per second fully meet if not excel the requirements of standardized left 
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ventricular structure and function assessment protocols used in today’s CMR practice 
(111). The real time FLASH images of the aorta demonstrated the extended anatomic 
coverage of the 16 channel bow tie antenna array along the head-feet direction 
including details of the liver and the spine without B1+ signal voids (Figure 9). Real time 
imaging also provides opportunities for high spatiotemporal resolution UHF-BMR 
including tracking abdominal and pelvic moving pattern and for assessing small 
bowel disease (147,148). 
 
Renal Imaging 
The potential spatial resolution advantage of UHF-BMR would benefit the 
evaluation of patients with renal insufficiency, renal tissue hypoperfusion/hypoxia, 
effects of iodinated x-ray contrast media, or acute kidney injury and its progression to 
chronic kidney disease, and preoperative evaluation of renal vasculature and 
anatomy (126,127,149,150). The feasibility of renal MRI at 7T was demonstrated at an 
early stage of the development process (5). At this stage it was concluded that T1 
weighted gradient-echo MRI provides best image quality and excellent conspicuity 
of the non-enhanced vasculature which is beneficial for time of flight MRA (Figure 10). 
The feasibility of dynamic contrast enhanced T1-weighted renal imaging (Figure 10) 
was demonstrated (4). Image quality obtained for T2 weighted FSE imaging was 
strongly impaired because of signal inhomogeneities.  
The evaluation of the potential of high spatial resolution MRA of the renal 
vasculature using contrast enhanced (4) and non-contrast enhanced (7) techniques 
at 7.0 showed enhanced vessel delineation and vessel conspicuity. First pass 
perfusion renal MRA revealed an improvement in vessel delineation versus non-
contrast acquisitions (11). 
 In more sophisticated implementations of renal MRA at 7.0 T dynamically 
applied B1+ shimming solutions were incorporated into a non-contrast enhanced 
renal MRA technique that makes use of two B1+-shim sets (12): one customized for B1+ 
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efficiency maximization to drive contrast preparation and another one tailored for 
uniform low flip angle imaging (12). This approach supports high resolution imaging of 
the renal vasculature derived from low flip angle gradient-echo acquisitions.  
Numerous (pre)clinical studies underscored the growing scope of T2* sensitized 
renal MRI and its value for the noninvasive assessment of renal oxygenation and 
perfusion (150). To further the capabilities of renal imaging it is compelling to advance 
high spatial resolution imaging and T2* mapping of the kidney at 7.0 T. 
 
Liver Imaging 
Liver imaging constitutes a growing fraction of clinical MRI including the 
assessment of focal liver lesions, diffuse liver disease and liver vessel pathologies. A 
typical liver exam consists of T2-weighted imaging with and without fat saturation, and 
T1-weighted gradient-echo imaging prior to and following administration of contrast 
media. Since UHF-BMR becomes more widespread, its advantages can be potentially 
exploited to drive the spatial resolution into the sub-millimeter range and to enhance 
the liver vessel/parenchyma contrast. T1 weighted imaging of the liver was shown to 
support whole liver coverage (Figure 11a) and high details of subtle liver structures 
without the need of contrast agent application (Figure 11b) (21). Besides the 
gallbladder and the great vessels, capillaries in the dimension of half a millimeter of 
diameter were clearly identifiable due to the superb spatial resolution of (0.3x0.3x2.5) 
mm3 (Figure 11c) which is superior to that commonly achieved in clinical settings at 
1.5 T and 3.0 T (135,136). Contrast-enhanced T1-weighted MR cholangiography (MRC) 
using 3D gradient-echo techniques facilitated a uniform depiction of the intra- and 
extrahepatic biliary tract at 7.0 T with the depiction of the intrahepatic bile ducts 
being superior to MRC at 3.0 T (19).  The use of multi-spoke slice-selective parallel 
transmit RF pulses would be beneficial for mitigating B1+ inhomogeneities observed for 
liver MRI at 7T (15). Unlike B1+ field distribution, B0 uniformity was found to be 
p a g e  | 29 
 
acceptable as indicated by rather uniform T2* across the liver (Figure 11d) (135) with 
T2*≈10 ms for the parenchyma and T2*≈10 ms for the large liver vessels.  
Liver fat/water imaging was reported to be feasible with fat and water being 
correctly classified across the full field of view (135). Providing MR-based liver fat and 
volume could be utilized as endpoints in patients with non-alcoholic fatty liver disease 
or obesity. It is challenging though, to incorporate fat-water separation into FSE 
commonly used for diagnostic T2-weighted liver and abdominal imaging which 
requires uniform fat suppression.  To address this issue a slice-selective gradient 
reversal technique was applied, which provided uniform fat suppression with 
moderate tissue signal loss of approximately 20% (18). This approach was combined 
with the TIAMO technique (97) which facilitated delineation between fat and bright 
liquids in single-shot FSE (18). The progress in FSE imaging of the liver at 7.0 T opens 
opportunities for diffusion weighted imaging of the liver free of geometric distortion, 
which is elusive for DWI-EPI because of susceptibility induced distortions. Working 
towards this direction would provide means for evaluating hepatic fibrosis. 
 
Prostate Imaging 
Indications for MRI of the prostate include the evaluation of prostate cancer 
and MRI guided prostate biopsy (151-154). The sensitivity gain at 7.0 T holds the 
promise to obviate the use of endorectal coils for prostate MRI. Early explorations into 
prostate MRI at 7.0 T demonstrated high quality images facilitated by transceiver 
arrays in conjunction with patient specific local B1+ shimming (2). With this signal 
homogeneity and spatial resolution clear delineation of anatomical features in the 
prostate and surrounding structures including the neurovascular bundle, the rectum, 
the urethra, the transition zone, the peripheral zone and the fibromuscular tissue  was 
achieved (2). Careful examination of the B1+ efficiency and B1+ uniformity of an 
endorectal coil and an eight-element microstrip transceiver  array at 7.0 T  suggested 
the use of the microstrip array for T1- and T2 weighted prostate imaging, whereas the 
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endorectal coil was considered to be the best choice for spectroscopic studies (6).  
Further advancements in B1+ efficiency and uniformity together with a four-fold 
reduction in local RF power deposition and a 40% SNR increase in the center of the 
prostate were accomplished by adding an extra stripline element to the 
conventional endorectal coil (9). The lessons learned from these developments 
culminated in high quality T2 weighted FSE imaging of the human prostate using an 
external transceive body array coil (17) in healthy subjects and in patients with 
prostate cancer (Figure 12) (17). This pioneering study demonstrated that prostate 
tumors diagnosed or confirmed with MR-guided biopsy or prostatectomy were well 
visualized with 7.0 T MRI (17). 
 
 
Sodium MRI 
Sodium MRI (23Na MRI) is an emerging approach for gaining better insights into 
cellular metabolism with a broad spectrum of biomedical imaging research 
applications (155). Previous studies eloquently reported credible data on 23Na MRI of 
the heart and demonstrated that 23Na-MRI is suitable for the detection and 
assessment of acute and chronic heart disease (156). The rapidly decaying 23Na 
signal and the low sensitivity of 23Na MRI versus 1H MR constitute a challenge for 
clinical 23Na CMR. Once clinically feasible, sodium MRI holds the promise to become 
a valuable diagnostic tool for classifying viable from non-viable tissue in ischemic 
infarct patients.  Recognizing the sensitivity gain and yet unimpaired transmission field 
homogeneity (43) due to the comparably low 23Na resonance frequency which is 
close to 1H MRI at 1.5 T it is conceptually appealing to pursue cardiac 23Na MRI at 7.0 
T at clinically acceptable acquisition times. To approach this goal a local four-
element transceiver RF surface coil customized for cardiac 23Na MR at 7.0 T was 
employed to derive 23Na images of the heart (Figure 13) with a resolution of (6x 6 x 6) 
mm3 using a density-adapted 3D radial acquisition technique (157). These efforts also 
demonstrated that the sensitivity gain at 7.0 T enables CINE 23Na imaging of the 
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beating heart using a temporal resolution of 100 ms supported by retrospectively 
gated, density-adapted 3D projection reconstruction (158). 
Beyond viability imaging 23Na MR promises to change the landscape for 
monitoring Na+ disposition in the body which is important in cardiovascular research. 
A high dietary salt (sodium chloride) intake and the metabolic syndrome are the 
driving forces for risk factors of the cardiovascular epidemic. Sodium metabolism is 
closely linked mechanistically to the metabolic syndrome. Na+ can be bound to 
proteoglycans that are particularly abundant in the skin. Earlier determinations of skin 
and muscle Na+ concentrations in humans were reduced to chemical analysis 
following excision of material. Such an approach is not clinically acceptable. This 
state-of-affairs suggests assessment of sodium content using UHF-MR. The spatial 
resolution enhancements over 3.0 T setups revealed for the first time the enormous 
Na+ content of the human skin with a millimeter in-plane spatial resolution and a <11% 
intra-subject variability (83,159). It stands to reason that the combination of high 
resolution 1H UHF-MR and sophicticated 23Na MR image reconstruction techniques 
that include prior knowledge from 1H MRI will enable even higher spatial resolutions 
for 23Na MR (160).  
23Na MRI has been also employed to examine renal sodium content at 7.0 T 
(Figure 13).  These efforts showed that renal 23Na concentration increases from the 
cortex to medullary pyramid direction (20). 23Na T2* relaxation times were reported to 
differ between the cortex (17.9±0.8 ms) and medulla (20.6±1.0 ms) (20). This affords 
the use of clinical imaging protocols built on gradient-echo techniques which would 
be beneficial for translating renal 23Na MRI into broader in vivo studies at 7.0 T.   
The preliminary results suggest that 23Na MRI at 7.0 T can help to unlock 
questions regarding Na+ balance and Na+ storage functions of kidney, skin and 
muscle with the ultimate goal to provide imaging means for diagnostics and for 
guiding treatment decisions in cardiovascular and metabolic diseases.  
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Phosphorous MR 
Phosphorus MR affords in vivo insights into the energy metabolism and is an 
ideal candidate to benefit from the sensitivity gain and improved frequency 
dispersion at higher fields. To demonstrate the sensitivity gain, careful juxtaposition 
between cardiac 31P-MRS at 7.0 T and 3.0 T was conducted (52). These pioneering 
studies revealed marked superiority of cardiac 31P spectra at 7T relative to 3T (Figure 
14). SNR improvements of 2.8 for PCr (52) together with a reduced standard deviation 
for the PCr/ATP ratio were observed. This gain resulted in an enhanced quantification 
accuracy at 7.0 T. Myocardial 31P T1 relaxation times are shorter at 7.0 T versus 3.0 T. 
These improvements could permit scan time reductions versus 3.0 T and might 
eventually allow metabolic probing of dynamic processes. For all these reasons it was 
concluded that 7.0 T will become the field strength of choice for cardiac 31P MR 
spectroscopy tailored for probing myocardial energy metabolism (52).  
Probing phosphorylated metabolites with 31P MRS can be also used for 
prostate cancer characterization at 7.0 T (13). 31P spectroscopic imaging using an 
endorectal coil together with adiabatic excitation enabled the acquisition of 
phosphorous spectra covering the entire prostate with a spatial resolution of 4 cm3 in 
18 min (10) or of 5.1 cm3 in approximately 9 min (Figure 14). This achievement 
supported the detection of phosphocholine, phosphoethanolamine and inorganic 
phosphate that could serve as MR based biomarker for prostate cancer diagnostics. 
An exploratory study involving 15 patients with biopsy-confirmed prostate cancer 
showed distinct features of phospholipid metabolites in the prostate gland and its 
surrounding structures (22). However, no differences in the phosphorous metabolite 
ratios were found between prostate cancer and normal-appearing prostate tissue 
(22). These observations warrant optimization of 31P MRS technology including RF coil 
developments, evaluation of T1 relaxation times and detailing the impact of the 
Nuclear Overhauser Effect of phosphorus-containing metabolites at 7.0 T (23).  
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Practical Considerations  
 
Ancillary Devices  
Physiological motion and flow constraints dictate the viable window for data 
acquisition in CMR/BMR. Cardiac motion is commonly dealt with using 
electrocardiographic (ECG) gating techniques. ECG being an electrical 
measurement is corrupted by interference with electromagnetic fields and by 
magneto-hydrodynamic (MHD) effects (40). As UHF-MR becomes more widespread, 
the significance of artifact sensitivity of ECG recordings increases and with it the 
motivation for a practical hardware solution. To this end an MR-stethoscope which 
builds on the phonocardiogram and which is immune to interferences with 
electromagnetic fields has been proposed and evaluated for the pursuit of robust 
and safe cardiac gated/triggered UHF-CMR (27,33,161,162).  
BMR and CMR applications involve the injection of contrast media. Contrast 
agent application is most effective and reproducible using a power injector versus 
manual injection.  While many power injectors customized for MR are approved for 
use at 1.5 T and 3.0 T, assessment and certification of safety, functionality, flow rate, 
volume and timing fidelity remains an open task at 7.0 T. The electro-mechanical 
injector components positioned in the 7.0 T environment are of particular safety 
concern since the fringe field is stronger and larger versus a clinical 1.5 T or 3.0 T 
system.  Hence it is prudent to mount the powerhead on the wall inside of the 
scanner room. This approach might come at the cost of an increased length of the 
supply lines over a 1.5 T and 3.0 T setup. This issue can be fixed through recalibration 
of the power injector. 
 
Subjective Acceptance of UHF-BMR/CMR examinations  
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On the journey to broader clinical UHF-BMR/CMR applications it is of 
relevance to scrutinize how UHF-CMR examinations are tolerated by subjects. 
Practical concerns evoked by the physical size and mere length of today’s 7.0 T MR 
scanner and the paucity of data about ergonomic constraints, (dis)comfort and 
sensory side effects are driving the notion that UHF-BMR/CMR constitutes a challenge 
for subject tolerance of 7.0 T examinations per se. Realizing the lack of data a recent 
study examined the subjective acceptance during UHF-CMR in a cohort of 165 
healthy subjects (59). A questionnaire was used to examine the participant’s 
experience prior, during and after the UHF-CMR examination. Transient muscular 
contraction was documented in 12.7% of the questionnaires (59). Muscular 
contraction was reported to occur only during periods of scanning with the magnetic 
field gradients being rapidly switched. Dizziness during the study was reported by 
12.7% of the subjects (59). Taste of metal was documented by 10.1% of the study 
population. Light flashes were outlined by 3.6% of the entire cohort. 13% of the 
subjects reported side effects/observations which were not explicitly listed in the 
questionnaire but covered by the question about other side effects and observations 
(59). No severe side effects as vomiting or syncope after scanning occurred. No 
increase in heart rate was observed during the UHF-CMR exam versus the baseline 
clinical examination. To summarize, UHF-CMR examinations are well tolerated by 
healthy subjects. Broader observational and multi-center studies including patient 
cohorts with cardiac diseases are required to gain further insights into the subjective 
acceptance of UHF-CMR examinations.  
 
RF Power Deposition Considerations  
Radiofrequency pulses used in MR applications at low and high magnetic 
fields deposit RF power in tissue, which can be described by the specific absorption 
rate (SAR): 
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with the tissue conductivity , the root mean square of the electric field 	 and 
the tissue density . Excessive SAR levels might lead to elevated temperature levels 
making a careful SAR evaluation mandatory to confirm compliance with the RF 
power deposition limits given by the IEC standard 60601-2-33:2010 Ed.3 (163) for safe 
operation of transmit RF coils tailored for UHF-CMR/BMR (163). For this purpose it is 
circumspect that the safety assessment, the implemented safety measures, the 
technical documentation and the risk management file for the RF coil are evaluated 
and made available for implementation in clinical studies following a review and 
conformity declaration - confirming compliance with the relevant sections of IEC 
60601-2-33:2010 Ed.3 and IEC 60601-1:2005 Ed.3. - issued by an independent notified 
body rather than solely conducting an in-house assessment. In-house procedures 
make it challenging to comply with a standard since they may vary among 
institutions, depend on the different level of local expertise, might be compromised 
by the use of not clearly defined reference values and arbitrary tolerances for key 
parameters governing RF safety and last but not least are not independent. A notified 
body is an accredited test laboratory that is independent from manufacturer or 
distributor and that has been approved by an independent third party to perform 
tests within a defined test scope for medical devices and hence is entitled to 
examine whether a product or procedure complies with the requirements of a 
certain standard or an equivalent standard document.  
The IEC 60601-2-33:2010 Ed.3 technical standard defines limits for whole body 
average SAR (normal mode: 2.0 W/kg, 1st level controlled mode: 4.0 W/kg), which is 
used for large volume body RF coils commonly used for transmission at 1.5T and 3.0T. 
RF power deposition of local transceiver RF coil arrays used for UHF-BMR/CMR is 
limited by a more restrictive local SAR of 20W/kg for the trunk in 1st level controlled 
mode. This restriction implies (i) that the applicable RF power based on local SAR limits 
is lower than based on whole body or partial body SAR (164,165) and (ii) that more 
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power has to be applied in order to reach the same flip angle. In addition electrical 
conductivity is frequency dependent and increases for UHF-MR. This leads to a direct 
SAR increase as seen from equation 1 and an indirect SAR increase due to lower 
absolute B1+ per input power resulting from higher transmission losses in tissue. 
At UHF-MR the wavelength becomes sufficiently short versus the upper 
torso/abdomen/pelvis which affects the E field distribution inside the body and offsets 
some of the SAR predictions governed  by (166): 
 
            (2) 
 
RF power deposition is substantially affected by the geometry of the upper 
torso, by positioning of the RF coil with respect to the torso and the heart, by the RF 
coil design, by the number of RF transmission channels as well as by the RF driving 
conditions. Here EMF simulations are essential to provide an insight into the local SAR 
distribution. Figure 15 illustrates the /√/		 distribution for a 
cardiac optimized four channel TX/RX array for field strengths ranging from 1.5 T to 
14 T. For this purpose the TX/RX array was placed onto the anterior and posterior 
upper torso of the human voxel model “Duke” (96). For this configuration a lower B1+ is 
achieved for the given local SAR values when moving to higher frequencies. 
Consequently, a higher RF power deposition is needed to achieve the same flip 
angle at higher fields. For the setup simulated a SAR increase by a factor of 13.7 was 
observed for the mid-ventricular septum when moving from 1.5 T to 7.0 T. In 
comparison, the same myocardial region showed a factor of 3.5 SAR increase when 
moving from 7.0 T to 14.0 T. For an apical region a SAR increase of factor 8.1 was 
derived when moving from 1.5 T to 7.0 T and factor of approximately 2.2 was 
deduced for a B0 increase from 7.0 T to 14.0 T. The increase in local SAR to achieve 
the same flip angle is not as pronounced as reported for a single loop cardiac coil 
(167). This underlines that local SAR depends on the geometry of the 
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torso/abdomen/pelvis, on the position of the coil with respect to target anatomy, on 
the RF coil design, on the number of RF transmission channels as well as on the RF 
driving conditions.  
A change in amplitude and phase of each individual transmit channel – 
commonly used for B1+ shimming (1) or parallel transmission (104-107) - may induce 
significant alterations in local SAR. This behavior generates a need for explorations 
into concepts for SAR characterization of multi-channel transmission which is relatively 
new territory. While commercial configurations of multi-channel transmission at 3.0 T 
are already CE marked and FDA cleared multi-channel transmission configurations at 
7.0 T are still investigational devices. This constitutes a major road blocker en route to 
a broader range of UHF-BMR/CMR parallel transmission applications since the primary 
responsibility for safe use is shifted by the MR manufacturers to the end-users, which 
creates an asymmetry since it constitutes a subtly but importantly different situation 
than for "cleared" devices, where this primary responsibility falls to the manufacturers. 
This asymmetry provides stimulation to the imaging community to throw further 
intellectual weight behind the solution of the remaining issues. To achieve this goal, 
strategic research driven by joint efforts of thought leaders from industry, scientists, 
and clinicians should be devoted to the development of enhanced practical 
solutions for SAR assessment of multi-transmit configurations. In this light patient safety 
concepts and algorithms were recently proposed for SAR characterization of multi-
channel transmission including EMF simulations using human anatomical models to 
pre-calculate the electric field distributions of each individual channel (168-170). 
While being a valuable approach its main limitations are twofold: (i) SAR assessment is 
based exclusively on human voxel model simulations which may or may not reflect 
the specific situation of the given subject and (ii) the concept does not contain any 
provisions for RF waveforms deviating from those included in the calculations due to 
hardware infidelities or hardware malfunction. In this context a novel, comprehensive 
RF safety strategy for parallel transmission MR was recently put forward (171). The 
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proposed approach allows (i) SAR prediction prior to the scan and (ii) SAR supervision 
during the scan and hence provides means for offsetting SAR overestimation while still 
meeting the requirements of RF safety (171). For this purpose the comprehensive 
strategy comprises three stages: (i) SAR prediction using preprocessed numerical 
simulation data obtained for human body models derived from fater-water 
separated MRI of heathy volunteers positioned in supine position with the arms 
parallel to the torso; (ii) a preparation phase, where active decoupling and load 
compensation are used to ensure the predicted SAR matches the actual SAR applied 
to the subject; and (iii) supervision during the scan (171). The latter ensures that global 
and local SAR limits are not exceeded and that the RF waveforms applied are 
correct as predicted (171).  
On-the-fly SAR calculations including determination of momentary RF 
amplitudes and phases during the scan, real-time calculation of local SAR maxima 
and interruption of RF transmission in case SAR limits are exceeded constitutes a 
challenge. To address this issue several methods that significantly reduce the 
complexity without restriction to particular radiofrequency excitations were proposed 
(172-176). In a particular implementation it was demonstrated that by compressing 
complete body models into limited sets of matrices it is sufficient to consider only so-
called Virtual Observation Points (VOPs) and still obtain an adequate, conservative 
estimation of the maximum local SAR (173).  The VOPS approach affords substantial 
processing time savings for maximum local SAR evaluation and hence holds the 
promise to support online SAR assessment using pre-calculated electric fields of any 
arbitrary TX array configuration tailored for UHF-BMR/CMR. Ideally, the models used 
for simulations of electric fields to be delivered to the VOPS interface should involve 
subject specific geometry and tissue composition (177) resulting in individualized 
body SAR models that include conductive implants and devices. 
Although SAR is key for RF safety evaluations, temperature distribution - which 
is the cause of tissue damage based on RF heating - doesn’t follow SAR in a 
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straightforward manner (164). Thermoregulation and heat transfer inside the body 
(i.e. blood vessels) need to be considered while moving towards a more realistic 
scenario. Ongoing research focusses already on temperature modeling instead of 
SAR models, suggesting a thermal tissue damage threshold CEM43 known from 
thermal therapies (178,179). Here realistic thermal modelling based on 
electromagnetic field simulations and MR thermometry is essential to assess thermal 
distributions in vivo (180,181). These explorations will help to advance towards 
enhanced MR safety assessment for UHF-BMR/CMR CMR. This development is 
expected to include a drive towards controlled E-field steering and targeted SAR 
reduction technologies in electrically conductive implants, catheters and guide wires 
using parallel transmission to create excitations that induce minimal RF current in 
elongated conductors (182,183). An open minded look reveals that UHF-CMR parallel 
transmission technology perhaps forms an enabling platform to advance 
interventional CMR applications at 7.0 by using an MR antenna array to deliberately 
focus RF power in a controlled way (46). In this context potential applications could 
include (i) targeted RF guided drug release and image guided monitoring (184), (ii) 
localized contrast agent release and tracking or (ii) stem cell delivery to the 
myocardium afforded by local RF heating. One could even conduct a 
gedankenexperiment where targeted RF heating driven by multi-transmit UHF-MR 
technology is utilized in thermal therapies or even used for RF ablation versus today’s 
invasive intracardiac catheter ablation.  
 
Radiofrequency Heating of Conductive Devices 
En route to broader clinical UHF-BMR/CMR studies it is essential to gain a better 
insight into the interaction of passive conducting implants with RF fields. Considering 
an ever increasing population of patients with a history of stent implantation, 
detailing the interaction of stents with RF fields is of profound relevance for the 
advancement of UHF-BMR/CMR. This is not an easy task because of the many RF coil 
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and stent configurations available, yet becomes even more relevant when moving to 
many element transceiver arrays or even to large volume coils covering major 
sections of the body. 
At UHF-MR the RF wavelength (λ) in myocardial tissue and blood is sufficiently 
short (λ~12cm) to induce resonance effects at λ/4 - λ/2 (185) in coronary stents with a 
length of up to ~4cm, a dimension common in clinical practice (186). EMF simulations 
and RF heating experiments showed that temperature increase due to coronary 
stents does not exceed baseline RF heating if IEC standards for local and global SAR 
limits are strictly obeyed (41). While being very important these early studies did not 
employ a setup which resembles a clinical scenario (41). The need for RF heating 
assessment at B0≥7.0 T also prompted valuable research into RF induced heating of 
metallic arterial stents (187). The conclusions drawn are valuable but constrained to 
the very specific experimental setup used.  
Recognizing the opportunities for broader clinical UHF-MR studies RF induced 
heating of coronary stents was examined at 7.0 T (57,188). For this purpose EMF 
simulations were performed for a broad range of coronary stent configurations to 
detail electric fields and local SAR  as a function of stent diameter, stent length, stent 
position with respect to the RF transmission source and stent orientation versus the E-
field (57,188). To translate these results to arbitrary coronary stent geometries, arbitrary 
stent positions and arbitrary RF coil configurations an analytical approach for the 
assessment of EM fields induced in coronary stents was proposed. SAR1g induced by a 
stent (SAR1g stent) can be described by: 
 
baselinegstentg
SARnorientatiolengthdiameterfSAR 11 ),,()max( ⋅=                                  (3) 
 
   
with SAR1g baseline being the local SAR1g at the assumed stent position without the 
presence of a stent (57). Figure 16b shows an example of the dependence of 
induced stent SAR1g on stent length and stent orientation versus the E-field vector.  
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The analytical approach provides a fast way to estimate induced stent SAR 
levels. EMF simulations performed with a stent integrated in a human voxel model 
prove to be very time consuming. This is a particular practical obstacle if many-
element RF TX/RX arrays and a set of phase settings mimicking B1+-shimming or other 
parallel transmit applications are included. Benchmarking the analytical approach 
versus EMF simulations showed a good conservative estimation of induced SAR1g 
peak levels. A practical example is shown in Figure 16 using an 8 channel bow tie 
antenna RF coil array optimized for CMR at 7.0 T (Figure 1e). EMF simulations including 
the stent consumed >2 hours CPU and GPU time per phase setting (not including RF 
shim field combining and SAR calculations) while the analytical approach can be 
calculated in real-time. This example underscores the value of the proposed 
analytical approach for obeying regulatory RF power limits (163). The analytical 
approach is conceptually translatable to other implant configurations and can be 
conveniently incorporated into state-of-the art SAR prediction concepts (174,189) to 
provide SAR estimations induced by coronary stents and other conductive implants 
for arbitrary RF pulses used for transmission field shimming (2,49) or parallel transmission 
(105,106). To generalize, this approach provides a novel metric or design criteria for RF 
coils. E.g. to design RF coils (i) with low SAR levels in the vicinity of the stent or (ii) with 
SAR levels during the presence of the stent which do not exceed SAR levels without 
the presence of the stent (57).  
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Looking Beyond the Horizon 
While today’s lion’s share of UHF-MR examinations covers brain and 
neuroscience applications, cardiac and body MR are other fields that can benefit 
from UHF-MR. The eye-opening quality of recent anatomical and functional images, 
have created excitement in the (bio)medical and diagnostic imaging communities 
and have served as a driving force for application developments which culminated 
in the breadth and detail outlined in this review. This progress is no great surprise, but 
a number of challenges remain. These unsolved problems should not be hidden 
under the carpet, but rather act as a surface marker thanks to contributions made by 
the many forward-thinking researchers, clinician scientists and clinicians. This faith 
attracts resources, fosters collaborations across the banks of what sometimes appears 
like a wide river, and invites talent. All putting further weight behind solving the 
conundrum governed by the physics and engineering, with the ultimate goal to 
harmonize development of novel imaging technology tailored for BMR/CMR with 
added clinical value, simplicity and ease of use. Meanwhile, the pace of discovery is 
heartening and a powerful motivator to transfer the lessons learned from UHF-
BMR/CMR research into the clinical scenario. These efforts are fueled by the quest for 
advancing the capabilities of diagnostic MRI, today. A story worth following since the 
implications feed into a broad spectrum of MR physics, biomedical engineering, 
radiology, cardiology, internal medicine, oncology, nephrology, and other related 
fields of basic research and clinical science (190-193). Moreover, the benefits of 7.0 T 
BMR/CMR innovations will be more being seen at 3.0 T, where the suboptimal copy 
and paste approach to protocol migration from 1.5T is being supplanted by the sort 
of application-targeted redesign which is essential for UHF-CMR/BMR.   
 An open minded look reveals that the field of UHF-BMR/CMR is in a creative 
state of flux. It is too early in the exploration stage to make ultimate statements 
though. Technological advances spurred by the low wave length regime have 
already earned UHF-BMR/CMR the moniker of being a steam engine for innovation 
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along with the recognition of being advanced UHF-MR applications. The 
requirements of UHF-BMR/CMR are likely to pave the way for further advances in MR 
technology and MR systems design. With appropriate multi transmit systems that offer 
more than 16 TX channels each providing at least 4 kW peak power, an optimistically-
inclined scientist might envisage the implementation of high density transceiver arrays 
with 64 and more elements with the ultimate goal to break ground for a many 
element upper torso or even a body coil array. This vision continues to motivate new 
research on integrated multi-channel transmission systems (194), on RF coil design 
together with explorations into ideal current patterns yielding optimal signal-to-noise-
ratio  for UHF-BMR/CMR (72). It is also compelling to embark into the development of 
high density, multiple-channel on-coil transmit arrays which would help to reduce the 
losses in the RF chain (195).  The enlarged spectral resolution along with the sensitivity 
gain stands to reason to boost 7.0 T MR of a broad spectrum of metabolically relevant 
nuclei including 19F, 13C, 17O, 31P, 23Na, 39K and 35Cl (196-200). This research will drive 
explorations into metabolic MR and nanomolecular MR probing for which RF coil 
innovations is to be expected. Perhaps another development is the move toward 
CMR/BMR using reduced field of views zoomed into the target anatomy enabled by 
spatially selective excitation techniques which put the capabilities of parallel 
transmission technology to good use. Elimination of the information redundancy 
intrinsic to today’s BMR/CMR applications would change the imaging landscape and 
would help to offset the complexity of today’s BMR/CMR exams.  
It is no secret that the future of UHF-BMR/CMR will not end at 7.0 T and that the 
field is moving apace into this direction. On the MR physics side the field strives to 
extend activities designed to master MR electrodynamics at fields of B0≥7.0 T by 
progressing numerical simulations. The first pioneering reports on EMF simulations 
dealing with B1+, SAR and temperature distribution for cardiac MR at 10.5 T, 11.7 T or 
even 14.0 T  have been outlined in this review or were released recently (201). On the 
experimental side the recent progress of probing the local concentrations of fluorine, 
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sodium, potassium and chlorine at 7.0 T provide convincing reasons for wide bore 
magnets with B0≥7.0 T which spurred the installation of a 10.5 T whole-body MR system  
suitable for cardiac and body imaging (201). Alongside this progress there is intriguing 
news on potential future developments outlined in a report of the National Research 
Council dealing with high magnetic field science and its application(202). This report 
forwarded a call for a 20.0 Tesla wide bore MR system, a technical development 
inspired by the recent progress at 7.0 T, by the early experience with small animal MR 
at 21.1 T (203) as well as by the lessons learned from the design and safety evaluation 
of superconducting 13.0 T magnet outserts with a 50 cm bore size retrofitted with a 12 
T resistive insert to form a 25.0 T hybrid magnet tailored for structure research (204). 
Arguably, 1H MR at 20.0 T might be elusive in the first run. Yet, the frequencies of x-
nuclei at 20.0 T are below the 1H resonance frequency at 7.0 T, with the exception of 
31P and 19F. This makes technology established for 1H MR at 7.0 T ideal candidates to 
be perfected and fine-tuned for hetero-nuclear BMR/CMR MR at 20.0 T. For example 
the sensitivity gain at 20.0 T is expected to reduce scan times for 31P and 23 Na by a 
factor of 8 versus today’s 7.0 T capabilities. While this is, for the moment, merely a 
vision, it promises sodium MR with a sub-millimeter spatial resolution in 5-10 min scan 
time, and offers the potential for probing the heart with 31P spectroscopy in clinically 
acceptable scan times versus today’s groundbreaking studies using scan durations of 
approximately 2 hours. Also, recognizing the pace and momentum of UHF-MR, the 
MR vendors committed that there is no U-turn on the Tesla road. In fact they are now 
driving with full throttle to setup the next generation of whole body 7.0 T magnets. 
Thitherto UHF-BMR/CMR techniques remain in a state of creative flux and productive 
engagement in this area continues to drive further developments. 
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Figure Captions 
 
Figure 1:  
Examples of multi-channel transceiver arrays tailored for cardiac MR at 7.0 T. Top: 
Photographs of cardiac optimized 7.0 T transceiver coil arrays including (left to right) a 
four channel, an eight channel, a 16 channel and a 32 channel loop array 
configuration together with an eight channel and 16 channel bow tie antenna array. 
For all configurations the elements are used for transmission and reception. Four 
chamber (middle) and short axis (bottom) views of the heart derived from 2D CINE 
FLASH acquisitions using the RF coil arrays shown on top and a spatial resolution of 
(1.4 x 1.4. x 4.0) mm3.  
 
Figure 2:  
Examples of multi-channel transceiver arrays tailored for cardiac MR at 7.0 T.  Top: 
Photographs of a) an eight channel stripline array (61), b) an eight channel stripline 
array which uses automated tuning with piezoelectric actuators (54), c) an four 
channel electric dipole antenna array using fractionated dipoles along with 
meander structures (66-68), and d) an 8 channel dielectric resonant antenna array 
fabricated with high permittivity, low loss  ceramics (55). Four chamber (middle) and 
short axis (bottom) views of the heart derived from 2D CINE FLASH acquisitions using 
the RF coil arrays shown on top. Images courtesy of a) Mark E. Ladd, Stefan 
Maderwald and Oliver Kraff, Erwin L. Hahn Institute, University Duisburg-Essen, Essen, 
Germany; b) Matthew D. Robson, Radcliffe Department of Medicine, University of 
Oxford, Oxford, UK; c) Alexander Raaijmakers, Department of Radiotherapy, 
University Medical Centre Utrecht, Utrecht, The Netherlands and d) Sebastian 
Aussenhofer, C. J. Gorter Center for High Field Magnetic Resonance, Leiden University 
Medical Center, Leiden, The Netherlands. 
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Figure 3: 
Example for transmission field assessment with EMF simulations and experimental B1+ 
mapping using a building block equipped with for loop RF elements. For this purpose 
a cylindrical phantom setup was used in the simulations and in the experiments. a) 
Virtual model of the setup used for validation (RF shield and casing are not shown but 
included in the simulations). The experimental setup was arranged analogously to the 
virtual setup. b) Simulated B1+ distribution (absolute values) of four channels which 
form one curved building block. For B1+ evaluation transversal slices through the 
cylindrical phantom were positioned in alignment with the center of the loop 
elements. c) Absolute transmission fields derived from B1+ mapping of the 
experimental setup. d) Difference maps in percentage of the simulated results. The 
results demonstrate the qualitative and quantitative agreement between the 
numerical simulations and the measurements. 
 
Figure 4: 
Transmission field shaping using a 32 channel loop element transceiver array (Figure 
1d) (53). In this example of static B1+ shimming field shaping is based upon EMF 
simulations for a multi-oblique plane mimicking a four chamber view of the heart. Top: 
B1+ field distributions for the three phase setting modes including left) an element-wise 
phase setting approach, center) a block-wise optimized phase setting approach 
were the phase is set identical for four loop elements forming a 4- channel module 
and right) a CP like mode. The element-wise phase setting regime provided the most 
uniform B1+ fields across the heart which is marked by the orange ellipse. The building-
block wise RF shimming mode provided a more uniform B1+ distribution across the four 
chamber view of the heart versus the CP-like phase setting regime. Bottom: Summary 
of the phase values used for the three phase setting regimes. 
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Figure 5:  
End-diastolic short axis views covering the heart from the apex to the base derived 
from 2D CINE FLASH imaging (in-plane resolution (1.1 x 1.1) mm², slice thickness 2.5 mm, 
GRAPPA reduction factor 2,) using top) a 32 channel modular TX/RX loop array and 
bottom) a 16 channel modular TX/RX bow tie antenna array. Both array 
configurations provided rather uniform signal intensity and no major signal voids for 
slices covering the heart from the apex to the base. 
 
Figure 6: 
Four chamber views (1st row) and short axis views (3rd row) of the heart derived from 
2D CINE FLASH acquisitions (GRAPPA reduction factor 2) using a,b) a 32 channel 
modular TX/RX loop element array (Figure 1d) and c,d) a 16 channel modular TX/RX 
bow tie antenna array (Figure 1f). Different resolution were employed: a,c) 
standardized clinical protocol: in-plane resolution=(1.8 x 1.8x6.0) mm3, b) in-plane 
resolution (1.1 x 1.1x2.5 ) mm3 and d) in-plane resolution (0.8 x 0.8x2.5) mm3. 2nd row: 
Magnified views of the ventricular trabeculae, demonstrating that spatial resolution 
enhancements by a factor of six or even twelve versus standardized protocols used in 
current clinical practice improve the delineation of subtle anatomical details of the 
heart. Bottom) Analysis of the signal intensity in the short axis view using a profile along 
a circular trajectory inside the myocardium.  
 
Figure 7: 
Example for myocardial T2* mapping at 7.0 T. Top: T2* weighted short axis views of the 
heart for a mid-ventricular slice derived from multi-echo gradient-echo imaging at 7.0 
T. Images shown were obtained with echo times of TE=2.04 ms, TE=4.08 ms, TE=6.12 ms, 
TE=8.16 ms and TE=10.20 ms. A spatially adaptive non‐local means (SANLM) denoising 
filter was applied (205). Bottom: T2*colour maps of a short axis view of the heart 
derived from a series of T2* sensitized 2D CINE acquisitions covering the entire cardiac 
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cycle (5 cardiac phases out of a series of 21 cardiac phases are shown) overlaid to 
conventional 2D CINE FLASH images. 
 
Figure 8: 
Examples for emerging UHF-CMR applications: a) high resolution image of the right 
coronary artery acquired with a spatial resolution of (0.45 x 0.45 x1.2) mm3  which was 
facilitated by a navigator gated free breathing 3D gradient-echo acquisition in 
conjunction with spectrally selective adiabatic inversion recovery at 7.0 T (courtesy of 
Maurice M. Bizino and Hildo Lamb, Department of Radiology, Leiden University 
Medical Center, Leiden, The Netherlands). b) fat-water separated (gray scale: water 
image, colour scale: fat image) coronary artery imaging showing the left main 
coronary artery using the DIXON approach at 7.0 T. c) black blood imaging of a short 
axis view of the heart derived from high spatial resolution ((0.9 x 0.9 x 4.0) mm3) fast 
spin-echo imaging at 7.0 T. 
 
Figure 9:  
Examples derived from free breathing real time imaging of a mid-ventricular short axis 
view of the heart (left: systole, center: diastole) using an 8 channel bow tie antenna 
array (Figure 1e) and of the aorta (right) using an 16 channel bow tie antenna array 
(Figure 1f). Images were acquired at a rate of 30 frames per second using highly 
undersampled radial 2D FLASH with nonlinear inverse reconstruction at a spatial 
resolution of (1.2 x 1.2 x 6.0) mm3. The real time images of the aorta demonstrate the 
35 cm anatomic coverage of the 16 channel bow tie antenna array along the head-
feet direction including details of the liver and the spine without B1+ signal voids.  
 
Figure 10: 
Examples for renal MRI at 7.0 T. Top: TOF-MRA of the renal vasculature. The arrows 
point at the proximal (left) and peripheral (right) segments of the renal arteries. The 
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dashed arrow points at the superior mesenteric artery. The dotted arrows 
demonstrate the venous overlay, by means of the inferior vena cava and left renal 
vein. Bottom: Non-enhanced (left) and post-contrast (right, 1-M gadobutrol) T1-
weighted renal VIBE images. (images courtesy of Lale Umutlu, Erwin L. Hahn Institute 
for Magnetic Resonance Imaging, University Duisburg-Essen, Essen, Germany) 
 
 
Figure 11: 
Examples for liver MRI at 7.0 T. a) T1 weighted image of a central coronal abdominal 
slice showing a rather uniform excitation across the liver. The image was derived from 
gradient-echo imaging using a 32 channel TX/RX loop array (Figure 1d) and a voxel 
size of (0.4x0.4x2.5) mm³. b) Zoomed view of the area marked in red in a). c) Zoomed 
view of a T1 weighted axial slice covering the liver which was derived from gradient-
echo imaging using a 16 channel TX/RX loop array (Figure 1c) and a spatial resolution 
of (0.3x0.3x2.5) mm³. No contrast agent was applied. Subtle anatomic liver structures 
are clearly identifiable including capillaries in the dimension of a diameter of 0.5mm. 
d) Abdominal T2* map showing a rather uniform T2* distribution across the liver. 
 
Figure 12:  
Axial (left), sagittal (center) and coronal (right) T2-weighted images of the prostate of 
a patient (weight 98 kg, age 58 years, PSA 6 ng/ml) at 7.0 T (courtesy of Tom W. J. 
Scheenen Department of Radiology, Radboud University Medical Centre, Nijmegen, 
The Netherlands). For data acquisition a fast spin-echo imaging technique was used: 
TR=3000 ms, TE=71 ms, FOV=(240 x 180) mm2, matrix 320 x 240, in-plane spatial 
resolution=(0.75 x 0.75) mm2, phase encoding direction: anterior-posterior, slice 
thickness=3 mm, slice gap=0.6 mm, interleaved slice acquisition, 9 echoes, echo 
spacing 17.8 ms, readout bandwidth 116 Hz/pixel, NA=1, total acquisition time<2 min. 
To reduce RF power deposition a prolonged 1500 RF pulse as used for refocusing. An 8 
channel external stripline array was used for TX/RX and B1+-shimming was applied. 
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Figure 13: 
Top: Sodium images of a four chamber view of the heart (left) and a coronal view of 
the kidneys (right) acquired at 7.0 T. The 23Na image of the heart was acquired using 
a density-adapted 3D radial technique (157) with TE= 0.4 ms, TR=11 ms, TRO= 7.1 ms, 
TX amplitude 115V (~90% SAR) equivalent to a tip angle of 30-40°, number of 
projections=50000, number of averages=2 and a voxel size of (6 x 6 x 6) mm³. The 23Na 
image of the kidneys (courtesy of Stefan Haneder, Institute of Clinical Radiology and 
Nuclear Medicine, University Medical Center Mannheim, Heidelberg University, 
Heidelberg, Germany) was acquired with a spatial resolution of (4 x 4 x 5) mm3 using 
a 3D Cartesian spoiled gradient-echo sequence with a variable echo time scheme 
and a highly asymmetric readout (FOV=(256×256) mm2; matrix size=64×64; number of 
slices=24; echo time (TE)=4.19 ms; TR=49 ms, total scan time=approximately 40 min). 
Bottom: 1H four chamber view  of the heart (left) derived from 2D CINE gradient-echo 
imaging at 7.0 T and 1H coronal view of the kidney obtained at 3.0 T (right).  
 
Figure 14: 
Examples for 31P MR spectroscopy left) of the heart (courtesy of Christopher Rodgers, 
Radcliffe Department of Medicine, University of Oxford, Oxford, UK) and right) of the 
prostate (courtesy of Tom W. J. Scheenen Department of Radiology, Radboud 
University Medical Centre, Nijmegen, The Netherlands). Left: Comparison of single 
voxel 31P spectra of the human heart obtained at 3.0T (blue) and at 7.0 T (red). The 
voxel used for 31P MRS was placed in the middle of the interventricular septum as 
illustrated in the short axis view of the heart obtained from a 2D CINE FLASH localizer 
scan at 7.0 T. 31P MRS at 7.0 T provided an SNR advantage over 31P MR spectroscopy 
at 3.0 T. Right: 31P spectra of a 72-year-old patient with prostate cancer (Gleason 
score, 4+5; volume, 1.5 cm3) in the peripheral zone on the right side of the gland. The 
tumor lesion is indicated by white arrows on the transversal T2-weighted image. The 
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spectral map shows good quality of 31P spectra across the whole prostate.  31P 
spectra of the tumor (red circle, red frame) and healthy region (green circle, green 
frame) are shown separately with the following resonances: phosphoethanolamine 
(PE), phosphocholine (PC), two phosphate peaks (Pi1 and Pi2), 
glycerophosphoethanolamine (GPE), glycerophosphocholine (GPC), 
Phosphocreatine (PCr), gamma-ATP and alpha-ATP. 31P spectra were derived from 
spectroscopic imaging using a pulse acquire sequence with a 45 degree  adiabatic 
excitation BIR-4 pulse (duration=8 milliseconds), TR=1.5 ms,  FOV=(120 x120x120) mm3; 
matrix size=10 x10x10, number of averages=12 resulting in voxel volumes of 5.1 cm3 
after apodization with a Hanning filter of the k-space weighted sampling. Total 
acquisition time was 9 minutes 51 seconds. 
 
 
Figure 15:  
B1+ distribution and RF power deposition derived from EMF simulations at 1.5 T, 3.0 T, 
7.0 T, 11.7.0 T and 14.0 T using a four channel TX/RX loop array and the torso of the 
human voxel model “Duke”. For each field strength B1+ efficiency distribution is scaled 
to the maximum local SAR. For each configuration identical phase settings are used 
for B1+ and local SAR (10g average, 1W input power) calculations. The /√/
		 distribution is shown for 64 MHz 128 MHz, 300 MHz, 500 MHz and 600 
MHz and normalized to an efficiency of 30.//√/0. B1+ uniformity is 
substantially reduced for the short wave length regime for B0≥7.0 T. For the maximum 
input power of the coils, which is dictated by MR safety regulations that forbid 
overriding of maximum local SAR, a lower B1+ field is generated while moving from 1.5 
T to 14.0 T. This demonstrates that a higher average power is required for the 
excitation pulse to reach the same flip angle at higher MR frequencies. Given a 
higher average power and assuming that TR is not prolonged, RF power deposition 
shows to be significantly enhanced at UHF-MR frequencies ranging between 300 MHz 
(7.0 T) and 600 MHz (14.0 T).  
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Figure 16: 
EMF simulations using the human voxel model „Duke“ from the virtual family and an 8 
channel transmit/receive bow tie electric dipole array. a) Schematic views of the 
positioning of the anterior bow tie RF antennas on the anterior chest of the human 
voxel model and coronal view of SAR1g baseline distribution for a plane through the 
target position without the stent equivalent being present. b) Surface plot of SAR1g stent 
derived from equation 3 for baseline SAR1g baseline for an input power of 1W/kg. A stent 
length ranging from 10-40 mm and a stent rotation versus the main E-field vector 
ranging from 0-900 was applied. c) Coronal view of SAR1g stent distribution for a plane 
through the target position with the stent equivalent being present. d)  Simulated 
maximum baseline SAR1g baseline and SAR1g stent for the stent equivalent using eight 
randomly generated phase settings compared to the SAR estimation deduced from 
the analytical approach (equation 3). While conservatively overestimating SAR, SAR 
estimation using equation 3 was able to predict the induced SAR1g levels without the 
need to perform extra time consuming EMF simulations with a stent being present in 
the simulation model. 
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Figure 1:  
Examples of multi-channel transceiver arrays tailored for cardiac MR at 7.0 T. Top: Photographs of cardiac 
optimized 7.0 T transceiver coil arrays including (left to right) a four-channel, an eight channel, a 16 channel 
and a 32 channel loop array configuration together with an eight channel and 16 channel bow tie antenna 
array. For all configurations the elements are used for transmission and reception. Four chamber (middle) 
and short axis (bottom) views of the heart derived from 2D CINE FLASH acquisitions using the RF coil arrays 
shown on top and a spatial resolution of (1.4 x 1.4. x 4.0) mm3.  
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Figure 2:  
Examples of multi-channel transceiver arrays tailored for cardiac MR at 7.0 T.  Top: Photographs of a) an 
eight channel stripline array (59), b) an eight channel stripline array which uses automated tuning with 
piezoelectric actuators (54), c) an four-channel electric dipole antenna array using fractionated dipoles along 
with meander structures (64-66), and d) an 8 channel dielectric resonant antenna array fabricated with high 
permittivity, low loss  ceramics (55). Four chamber (middle) and short axis (bottom) views of the heart 
derived from 2D CINE FLASH acquisitions using the RF coil arrays shown on top. Images courtesy of a) Mark 
E. Ladd, Stefan Maderwald and Oliver Kraff, Erwin L. Hahn Institute, University Duisburg-Essen, Essen, 
Germany; b) Matthew D. Robson, Radcliffe Department of Medicine, University of Oxford, Oxford, UK; c) 
Alexander Raaijmakers, Department of Radiotherapy, University Medical Centre Utrecht, Utrecht, The 
Netherlands and d) Sebastian Aussenhofer, C. J. Gorter Center for High Field Magnetic Resonance, Leiden 
University Medical Center, Leiden, The Netherlands.  
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Figure 3:  
Example for transmission field assessment with EMF simulations and experimental B1
+ mapping using a 
building block equipped with for loop RF elements. For this purpose a cylindrical phantom setup was used in 
the simulations and in the experiments. a) Virtual model of the setup used for validation (RF shield and 
casing are not shown but included in the simulations). The experimental setup was arranged analogously to 
the virtual setup. b) Simulated B1
+ distribution (absolute values) of four channels which form one curved 
building block. For B1
+ evaluation transversal slices through the cylindrical phantom were positioned in 
alignment with the center of the loop elements. c) Absolute transmission fields derived from B1
+ mapping of 
the experimental setup. d) Difference maps in percentage of the simulated results. The results demonstrate 
the qualitative and quantitative agreement between the numerical simulations and the measurements.  
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Figure 4:  
Transmission field shaping using a 32 channel loop element transceiver array (Figure 1d) (53). In this 
example of static B1
+ shimming field shaping is based upon EMF simulations for a multi-oblique plane 
mimicking a four chamber view of the heart. Top: B1
+ field distributions for the three phase setting modes 
including left) an element-wise phase setting approach, center) a block-wise optimized phase setting 
approach were the phase is set identical for four loop elements forming a 4 channel module and right) a CP 
like mode. The element-wise phase setting regime provided the most uniform B1
+ fields across the heart 
which is marked by the orange ellipse. The building-block wise RF shimming mode provided a more uniform 
B1
+ distribution across the four chamber view of the heart versus the CP-like phase setting regime. Bottom: 
Summary of the phase values used for the three phase setting regimes.  
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Figure 5:  
End-diastolic short axis views covering the heart from the apex to the base derived from 2D CINE FLASH 
imaging (in-plane resolution (1.1 x 1.1) mm², slice thickness 2.5 mm, GRAPPA reduction factor 2,) using 
top) a 32 channel modular TX/RX loop array and bottom) a 16 channel modular TX/RX bow tie antenna 
array. Both array configurations provided rather uniform signal intensity and no major signal voids for slices 
covering the heart from the apex to the base.  
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Figure 6:  
Four chamber views (1st row) and short axis views (3rd row) of the heart derived from 2D CINE FLASH 
acquisitions (GRAPPA reduction factor 2) using a,b) a 32 channel modular TX/RX loop element array (Figure 
1d) and c,d) a 16 channel modular TX/RX bow tie antenna array (Figure 1f). Different resolution were 
employed: a,c) standardized clinical protocol: in-plane resolution=(1.8 x 1.8x6.0) mm3, b) in-plane 
resolution (1.1 x 1.1x2.5 ) mm3 and d) in-plane resolution (0.8 x 0.8x2.5) mm3. 2nd row: Magnified views 
of the ventricular trabeculae, demonstrating that spatial resolution enhancements by a factor of six or even 
twelve versus standardized protocols used in current clinical practice improve the delineation of subtle 
anatomical details of the heart. Bottom) Analysis of the signal intensity in the short axis view using a profile 
along a circular trajectory inside the myocardium.  
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Figure 7:  
Example for myocardial T2* mapping at 7.0 T. Top: T2* weighted short axis views of the heart for a mid-
ventricular slice derived from multi-echo gradient-echo imaging at 7.0 T. Images shown were obtained with 
echo times of TE=2.04 ms, TE=4.08 ms, TE=6.12 ms, TE=8.16 ms and TE=10.20 ms. A spatially adaptive 
non‐local means (SANLM) denoising filter was applied (191). Bottom: T2*colour maps of a short axis view of 
the heart derived from a series of T2* sensitized 2D CINE acquisitions covering the entire cardiac cycle (5 
cardiac phases out of a series of 21 cardiac phases are shown) overlaid to conventional 2D CINE FLASH 
images.  
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Figure 8:  
Examples for emerging UHF-CMR applications: a) high resolution image of the right coronary artery acquired 
with a spatial resolution of (0.45 x 0.45 x1.2) mm3  which was facilitated by a navigator gated free 
breathing 3D gradient-echo acquisition in conjunction with spectrally selective adiabatic inversion recovery 
at 7.0 T (courtesy of Maurice M. Bizino and Hildo Lamb, Department of Radiology, Leiden University Medical 
Center, Leiden, The Netherlands). b) fat-water separated (gray scale: water image, colour scale: fat image) 
coronary artery imaging showing the left main coronary artery using the DIXON approach at 7.0 T. c) black 
blood imaging of a short axis view of the heart derived from high spatial resolution ((0.9 x 0.9 x 4.0) mm3) 
fast spin-echo imaging at 7.0 T.  
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Figure 9:  
Examples derived from free breathing real time imaging of a mid-ventricular short axis view of the heart 
(left: systole, center: diastole) using an 8 channel bow tie antenna array (Figure 1e) and of the aorta (right) 
using an 16 channel bow tie antenna array (Figure 1f). Images were acquired at a rate of 30 frames per 
second using highly undersampled radial 2D FLASH with nonlinear inverse reconstruction at a spatial 
resolution of (1.2 x 1.2 x 6.0) mm3. The real time images of the aorta demonstrate the 35 cm anatomic 
coverage of the 16 channel bow tie antenna array along the head-feet direction including details of the liver 
and the spine without B1
+ signal voids.  
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Figure 10:  
Examples for renal MRI at 7.0 T. Top: TOF-MRA of the renal vasculature. The arrows point at the proximal 
(left) and peripheral (right) segments of the renal arteries. The dashed arrow points at the superior 
mesenteric artery. The dotted arrows demonstrate the venous overlay, by means of the inferior vena cava 
and left renal vein. Bottom: Non-enhanced (left) and post-contrast (right, 1-M gadobutrol) T1-weighted 
renal VIBE images. (images courtesy of Lale Umutlu, Erwin L. Hahn Institute for Magnetic Resonance 
Imaging, University Duisburg-Essen, Essen, Germany)  
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Figure 11:  
Examples for liver MRI at 7.0 T. a) T1 weighted image of a central coronal abdominal slice showing a rather 
uniform excitation across the liver. The image was derived from gradient-echo imaging using a 32 channel 
TX/RX loop array (Figure 1d) and a voxel size of (0.4x0.4x2.5) mm3. b) Zoomed view of the area marked in 
red in a). c) Zoomed view of a T1 weighted axial slice covering the liver which was derived from gradient-
echo imaging using a 16 channel TX/RX loop array (Figure 1c) and a spatial resolution of (0.3x0.3x2.5) 
mm3. No contrast agent was applied. Subtle anatomic liver structures are clearly identifiable including 
capillaries in the dimension of a diameter of 0.5 mm. d) Abdominal T2* map showing a rather uniform T2* 
distribution across the liver.  
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Figure 12:  
Axial (left), sagittal (center) and coronal (right) T2-weighted images of the prostate of a patient (weight 98 
kg, age 58 years, PSA 6 ng/ml) at 7.0 T (courtesy of Tom W. J. Scheenen Department of Radiology, 
Radboud University Medical Centre, Nijmegen, The Netherlands). For data acquisition a fast spin-echo 
imaging technique was used: TR=3000 ms, TE=71 ms, FOV=(240 x 180) mm2, matrix 320 x 240, in-plane 
spatial resolution=(0.75 x 0.75) mm2, phase encoding direction: anterior-posterior, slice thickness=3 mm, 
slice gap=0.6 mm, interleaved slice acquisition, 9 echoes, echo spacing 17.8 ms, readout bandwidth 116 
Hz/pixel, NA=1, total acquisition time<2 min. To reduce RF power deposition a prolonged 1500 RF pulse as 
used for refocusing. An 8 channel external stripline array was used for TX/RX and B1
+-shimming was 
applied.  
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Figure 13:  
Top: Sodium images of a four chamber view of the heart (left) and a coronal view of the kidneys (right) 
acquired at 7.0 T. The 23Na image of the heart was acquired using a density-adapted 3D radial technique 
(155) with TE= 0.4 ms, TR=11 ms, TRO= 7.1 ms, TX amplitude 115V (~90% SAR) equivalent to a tip angle 
of 30-40°, number of projections=50000, number of averages=2 and a voxel size of (6 x 6 x 6) mm3. The 
23Na image of the kidneys (courtesy of Stefan Haneder, Institute of Clinical Radiology and Nuclear Medicine, 
University Medical Center Mannheim, Heidelberg University, Heidelberg, Germany) was acquired with a 
spatial resolution of (4 x 4 x 5) mm3 using a 3D Cartesian spoiled gradient-echo sequence with a variable 
echo time scheme and a highly asymmetric readout (FOV=(256×256) mm2; matrix size=64×64; number of 
slices=24; echo time (TE)=4.19 ms; TR=49 ms, total scan time=approximately 40 min). Bottom: 1H four 
chamber view  of the heart (left) derived from 2D CINE gradient-echo imaging at 7.0 T and 1H coronal view 
of the kidney obtained at 3.0 T (right).  
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Figure 14:  
Examples for 31P MR spectroscopy left) of the heart (courtesy of Christopher Rodgers, Radcliffe Department 
of Medicine, University of Oxford, Oxford, UK) and right) of the prostate (courtesy of Tom W. J. Scheenen 
Department of Radiology, Radboud University Medical Centre, Nijmegen, The Netherlands). Left: 
Comparison of single voxel 31P spectra of the human heart obtained at 3.0T (blue) and at 7.0 T (red). The 
voxel used for 31P MRS was placed in the middle of the interventricular septum as illustrated in the short 
axis view of the heart obtained from a 2D CINE FLASH localizer scan at 7.0 T. 31P MRS at 7.0 T provided an 
SNR advantage over 31P MR spectroscopy at 3.0 T. Right: 31P spectra of a 72-year-old patient with prostate 
cancer (Gleason score, 4+5; volume, 1.5 cm3) in the peripheral zone on the right side of the gland. The 
tumor lesion is indicated by white arrows on the transversal T2-weighted image. The spectral map shows 
good quality of 31P spectra across the whole prostate.  31P spectra of the tumor (red circle, red frame) and 
healthy region (green circle, green frame) are shown separately with the following resonances: 
phosphoethanolamine (PE), phosphocholine (PC), two phosphate peaks (Pi1 and Pi2), 
glycerophosphoethanolamine (GPE), glycerophosphocholine (GPC), Phosphocreatine (PCr), gamma-ATP and 
alpha-ATP. 31P spectra were derived from spectroscopic imaging using a pulse acquire sequence with a 45 
degree  adiabatic excitation BIR-4 pulse (duration=8 milliseconds), TR=1.5 ms,  FOV=(120 x120x120) 
mm3; matrix size=10 x10x10, number of averages=12 resulting in voxel volumes of 5.1 cm3 after 
apodization with a Hanning filter of the k-space weighted sampling. Total acquisition time was 9 minutes 51 
seconds.  
116x68mm (300 x 300 DPI)  
 
 
  
 
 
Figure 15:  
B1
+ distribution and RF power deposition derived from EMF simulations at 1.5 T, 3.0 T, 7.0 T, 11.7.0 T and 
14.0 T using a four channel TX/RX loop array and the torso of the human voxel model “Duke”. For each field 
strength B1
+ efficiency distribution is scaled to the maximum local SAR. For each configuration identical 
phase settings are used for B1
+ and local SAR (10g average, 1W input power) calculations. The 
B1
+/√kW/√(Max(local SAR10g) distribution is shown for 64 MHz 128 MHz, 300 MHz, 500 MHz and 600 MHz 
and normalized to an efficiency of 30µT/√kW √(W/kg). B1
+ uniformity is substantially reduced for the short 
wave length regime for B0≥7.0 T. For the maximum input power of the coils, which is dictated by MR safety 
regulations that forbid overriding of maximum local SAR, a lower B1
+ field is generated while moving from 
1.5 T to 14.0 T. This demonstrates that a higher average power is required for the excitation pulse to reach 
the same flip angle at higher MR frequencies. Given a higher average power and assuming that TR is not 
prolonged, RF power deposition shows to be significantly enhanced at UHF-MR frequencies ranging between 
300 MHz (7.0 T) and 600 MHz (14.0 T).  
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Figure 16:  
EMF simulations using the human voxel model „Duke“ from the virtual family and an 8 channel 
transmit/receive bow tie electric dipole array. a) Schematic views of the positioning of the anterior bow tie 
RF antennas on the anterior chest of the human voxel model and coronal view of SAR1g baseline distribution 
for a plane through the target position without the stent equivalent being present. b) Surface plot of SAR1g 
stent derived from equation 2 for baseline SAR1g baseline for an input power of 1W/kg. A stent length 
ranging from 10-40 mm and a stent rotation versus the main E-field vector ranging from 0-900 was applied. 
c) Coronal view of SAR1g stent distribution for a plane through the target position with the stent equivalent 
being present. d)  Simulated maximum baseline SAR1g baseline and SAR1g stent for the stent equivalent 
using eight randomly generated phase settings compared to the SAR estimation deduced from the analytical 
approach (equation 2). While conservatively overestimating SAR, SAR estimation using equation 2 was able 
to predict the induced SAR1g levels without the need to perform extra time consuming EMF simulations with 
a stent being present in the simulation model.  
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